Last data update: Apr 04, 2025 . (Total: 49030 publications since 2009 )
The emergent invasive serotype 4 ST10172 strain acquires vanG type vancomycin-resistance element: A case of a 66-year-old with bacteremic pneumococcal pneumonia
Chochua S , Beall B , Lin W , Tran T , Rivers J , Li Z , Arvay ML , Kobayashi M , Houston J , Arias S , McGee L . J Infect Dis 2025 231 (3) 746-750 ![]() ![]() ![]() We report a single case of invasive pneumococcal disease (IPD) by serotype 4, multilocus sequence type 10172 (ST10172) isolate with vanG-type resistance genes and reduced vancomycin susceptibility. The isolate was recovered during 2022 from a 66-year-old resident with bacteremic pneumococcal pneumonia within a Centers for Disease Control and Prevention Active Bacterial Core surveillance (ABCs) site hospital. The patient had received 23-valent pneumococcal polysaccharide vaccine and there was no evidence of concurrent or prior receipt of vancomycin in the previous year. Serotype 4/ST10172 IPD has shown increases within western ABCs sites, and the recent acquisition of a vanG element warrants close monitoring of this lineage. |
Implementation of core elements of antibiotic stewardship in long-term care facilities-National Healthcare Safety Network, 2019-2022
Luciano A , Kabbani S , Neuhauser MM , McCray TT , Robinson L , Rowe T , Gouin KA . Antimicrob Steward Healthc Epidemiol 2025 5 (1) e86 ![]() In 2022, uptake of all seven Core Elements of Antibiotic Stewardship were reported by 83% of US long-term care facilities. Though 98% of facilities reported access to an electronic health record, less than one-third utilized it for tracking antibiotic use, suggesting opportunities to leverage electronic data for automated reporting. |
Cross-resistance to 14-, 15- and 16-membered ring macrolides in Salmonella and Campylobacter
Singh R , Mukherjee S , Harrision LB , McDermott PF , Ge B , Gilbert JM , Li C , Whichard JM , Fortenberry GZ , Dessai U , Zhao S . J Antimicrob Chemother 2025 ![]() ![]() OBJECTIVES: This study aimed to gain a better understanding of how resistance determinants in Salmonella and Campylobacter contribute to 14-, 15- and 16-membered ring macrolide resistance phenotypes. METHODS: A total of 126 azithromycin-resistant (AziR) and -susceptible (AziS) [Salmonella (n = 45) and Campylobacter (n = 81)] isolates were selected for antimicrobial susceptibility testing (AST) and WGS. RESULTS: Seven functional macrolide resistance determinants, including erm(42), mef(C), mph(A), mph(E), mph(G), msr(E) and one point mutation (acrB_R717L) were previously identified in AziR Salmonella. These determinants resulted in an 8- and 16-fold 15-membered ring gamithromycin and azithromycin MIC50 increase, respectively, compared with AziS isolates, with a maximum MIC increase of up to 256. The same isolates also exhibited up to a 32-fold 14-membered ring erythromycin MIC50 increase. Salmonella with erm(42) or acrB_R717L showed up to 128-fold 16-membered ring macrolide tildipirosin MIC increase, compared with isolates that were susceptible or carrying other macrolide resistance genes. In Campylobacter, all AziR isolates had an MIC50 ranging from 32 to 4096 mg/L of the various membered ring macrolides, whereases all susceptible Campylobacter isolates had significantly lower MIC50 values, ranging from 0.25 to 4 mg/L. The MIC50 of the various ring macrolides for AziR Campylobacter isolates was 16- to 4096-fold higher when compared with AziS Campylobacter. CONCLUSIONS: Our study has revealed that the function of macrolide resistance genes in Salmonella can be associated with specific macrolide ring structures, whereas the single 23S rRNA mutation in Campylobacter results in significantly elevated MICs of all macrolides. for the various ring macrolides. |
Trends in intravenous antimicrobial start rates in outpatient hemodialysis centers, United States, 2012-2021
Wilson WW , Hua H , Li Q , Soe MM , Apata IW , Meng L , Bell JM , McDonald E , Edwards JR , Kabbani S , Novosad S . Antimicrob Steward Healthc Epidemiol 2025 5 (1) e87 ![]() Using National Healthcare Safety Network data, an interrupted time series of intravenous antimicrobial starts (IVAS) among hemodialysis patients was performed. Annual adjusted rates decreased by 6.64% (January 2012-March 2020) and then further decreased by 8.91% until December 2021. IVAS incidence trends have decreased since 2012, including during the early COVID-19 pandemic. |
Incidence of chronic kidney disease among adults with prediabetes in the CURE-CKD registry, 2013-2020
Alicic RZ , Duru OK , Jones CR , Kornowske LM , Daratha KB , Reynolds CL , Pavkov ME , Koyama AK , Xu F , Nicholas SB , Neumiller JJ , Norris KC , Hennessey KA , Tuttle KR . Diabetes Obes Metab 2025 ![]() |
Do type, timing and duration of life course non-employment differentially predict dementia risk? An application of sequence analysis
Pacca L , Gaye SA , Brenowitz WD , Fujishiro K , Glymour MM , Harrati A , Vable AM . Soc Sci Med 2025 372 117976 ![]() ![]() Periods out of employment may influence dementia, but characterizing lifecourse employment is difficult and prior research is sparse. This study used sequence and cluster analysis to characterize type, timing, and duration of lifecourse work gaps and estimate associations with dementia risk. Life History Mail Survey supplement to the U.S. Health Retirement Study participants (N = 5,945, 13.6 % of the Health and Retirement Study sample) reported lifecourse employment (full time or part time) and reasons and age of work gaps (unemployment, schooling, caregiving, or disability). Our exposure was gender-stratified employment trajectories from age 18-65, characterized using sequence analysis and cluster analysis. Our outcomes were algorithmically defined dementia probability scores and memory scores. We estimated the association between employment trajectories and dementia risk using generalized estimating equations and memory decline using linear mixed effect models, adjusted for age, gender, birthplace, and childhood socioeconomic status. We identified 11 employment trajectories for women (including predominant work, disability, unemployment, caregiving, retirement) and 10 for men (similar, but no caregiving). Compared to "predominant work", "disability" and "unemployment" trajectories were associated with higher dementia risk for men and women (e.g., disability among women: OR = 3.62; 95 % CI = 2.25, 5.81). Among women who cared for family, those who did not re-enter the labor force full-time had higher dementia risk (e.g. "family gap, go back part time": OR = 1.79; 95 % CI = 1.15, 2.79) compared to the predominant work cluster. Women who cared for family and returned to full-time work had similar cognitive outcomes to those in the predominant work cluster. Men who had long spells of part-time work also had elevated dementia risk (e.g. part time earlier: OR = 1.64; 95 % CI = 1.16, 2.57). Finally, women and men with long periods of unreported employment status had higher dementia risk than those in the predominant work trajectory. Results suggest the type, timing and duration of work gaps are differentially associated with dementia risk. Work gaps due to disability, unemployment or unreported employment status predicted higher dementia risk. Permanently leaving full-time work for caregiving predicted worse cognitive outcomes but temporary caregiving-related work interruptions did not. |
Cardiomyopathy prevalence and pregnancy-related mortality: United States, 2010 to 2020
Pathak I , Kuklina EV , Hollier LM , Busacker AA , Vaughan AS , Wright JS , Coronado F . JACC Advances 2025 4 (5) ![]() Background: Cardiomyopathies, particularly peripartum cardiomyopathy (PPCM), significantly contribute to maternal morbidity in the United States. Objectives: The authors estimated the prevalence and mortality of PPCM and other cardiomyopathies (OCMs) during pregnancy among women aged 15 to 55 years from 2010 to 2020 in the United States using a cross-sectional analysis of multiple data sets. Methods: We identified PPCM, OCM, and deliveries using International Classification of Diseases and diagnosis related group codes in the National Inpatient Sample. We calculated PPCM and OCM prevalence and adjusted prevalence ratios (aPRs) by select covariates. We identified pregnancy-related deaths from all cardiomyopathies combined and PPCM exclusively from 2015 to 2020 Pregnancy Mortality Surveillance System. We calculated pregnancy-related mortality ratios (PRMR) by select covariates. Results: The overall PPCM and OCM prevalence were 105.1 (95% CI: 101.8-108.3) and 76.1 (95% CI: 73.6-78.7) cases per 100,000 delivery hospitalizations, respectively. PPCM prevalence increased with advancing maternal age and decreasing neighborhood income and exhibited marked differences among Black and American Indian or Alaska Native women (aPR: 3.58 [95% CI: 3.36-3.82] and aPR: 1.96 [95% CI: 1.57-2.45], respectively). PPCM prevalence was higher among those with chronic hypertension and diabetes (aPR: 12.17 [95% CI: 11.51-12.88] and aPR: 6.25 [95% CI: 5.77-6.78], respectively). The overall cardiomyopathy and PPCM PRMR were 2.1 and 1.0 deaths per 100,000 live births, respectively. PRMR were highest among those aged ≥40 years and among American Indian and Black women (overall cardiomyopathy PRMR: 7.3, 6.0 deaths per 100,000 live births respectively). Conclusions: Intensifying efforts to address cardiomyopathies and enhance cardiovascular health before, during, and following pregnancy may reduce the burden of maternal morbidity. © 2025 The Authors |
Developing a computable phenotype for identifying children, adolescents, and young adults with diabetes using electronic health records in the DiCAYA Network
Shao H , Thorpe LE , Islam S , Bian J , Guo Y , Li P , Bost S , Dabelea D , Conway R , Crume T , Schwartz BS , Hirsch AG , Allen KS , Dixon BE , Grannis SJ , Lustigova E , Reynolds K , Rosenman M , Zhong VW , Wong A , Rivera P , Le T , Akerman M , Conderino S , Rajan A , Liese AD , Rudisill C , Obeid JS , Ewing JA , Bailey C , Mendonca EA , Zaganjor I , Rolka D , Imperatore G , Pavkov ME , Divers J . Diabetes Care 2025 ![]() OBJECTIVE: The Diabetes in Children, Adolescents, and Young Adults (DiCAYA) network seeks to create a nationwide electronic health record (EHR)-based diabetes surveillance system. This study aimed to develop a DiCAYA-wide EHR-based computable phenotype (CP) to identify prevalent cases of diabetes. RESEARCH DESIGN AND METHODS: We conducted network-wide chart reviews of 2,134 youth (aged <18 years) and 2,466 young adults (aged 18 to <45 years) among people with possible diabetes. Within this population, we compared the performance of three alternative CPs, using diabetes diagnoses determined by chart review as the gold standard. CPs were evaluated based on their accuracy in identifying diabetes and its subtype. RESULTS: The final DiCAYA CP requires at least one diabetes diagnosis code from clinical encounters. Subsequently, diabetes type classification was based on the ratio of type 1 diabetes (T1D) or type 2 diabetes (T2D) diagnosis codes in the EHR. For both youth and young adults, the sensitivity, specificity, and positive and negative predictive values (PPV and NPV, respectively) in finding diabetes cases were >90%, except for the specificity and NPV in young adults, which were slightly lower at 83.8% and 80.6%, respectively. The final DiCAYA CP achieved >90% sensitivity, specificity, PPV, and NPV in classifying T1D, and demonstrated lower but robust performance in identifying T2D, consistently maintaining >80% across metrics. CONCLUSIONS: The DiCAYA CP effectively identifies overall diabetes and T1D in youth and young adults, though T2D misclassification in youth highlights areas for refinement. The simplicity of the DiCAYA CP enables broad deployment across diverse EHR systems for diabetes surveillance. |
Extended-spectrum beta-lactamase shigella sonnei cluster among men who have sex with men in Chicago, Illinois-July-October 2022
Faherty EAG , Kling K , Barbian HJ , Qi C , Altman S , Dhiman VK , Teran R , Anderson K , Yuce D , Smith S , Richardson M , Vogelzang K , Ghinai I , Ruestow P , Heimler I , Menon A , Francois Watkins LK , Logan N , Kim DY , Pacilli M , Kerins J , Black S . J Infect Dis 2025 231 (3) 692-695 ![]() ![]() ![]() Drug-resistant shigellosis is increasing, particularly among men who have sex with men (MSM). During July-October 2022, an extended-spectrum β-lactamase-producing Shigella sonnei cluster of 9 patients was identified in Chicago, of whom 8 were MSM and 6 were festival attendees. The cluster also included 4 domestic travelers to Chicago. Sexual health care for MSM should include shigellosis diagnosis and prevention. |
The effects of vaccination status and age on clinical characteristics and severity of measles cases in the United States in the post-elimination era, 2001-2022
Leung J , Munir NA , Mathis AD , Filardo TD , Rota PA , Sugerman DE , Sowers SB , Mercader S , Crooke SN , Gastañaduy PA . Clin Infect Dis 2025 80 (3) 663-672 ![]() BACKGROUND: Despite high vaccine effectiveness, wild-type measles can occur in previously vaccinated persons. We compared the clinical presentation and disease severity of measles by vaccination status and age in the postelimination era in the United States. METHODS: We included U.S. measles cases reported from 2001 to 2022. Breakthrough measles was defined as cases with ≥1 documented dose of measles-containing vaccine, classic measles as the presence of rash, fever, and ≥1 symptoms (cough, coryza, or conjunctivitis), and severe disease as the presence of pneumonia, encephalitis, hospitalization, or death. Vaccinated cases with low- and high-avidity immunoglobulin G were classified as primary (PVF) and secondary (SVF) vaccine failures, respectively. RESULTS: Among 4056 confirmed measles cases, 2799 (69%) were unvaccinated, 475 (12%) were breakthrough infections, and 782 (19%) had unknown vaccination; 1526 (38%), 1174 (29%), and 1355 (33%) were aged <5, 5-19, and ≥20 years, respectively. We observed a general decline in classic presentation and severe disease with an increase in the number of doses and fewer complications among children aged 5-19 years compared to other age groups. Among 93 breakthrough cases with avidity results, 11 (12%) and 76 (82%) were classified as PVF and SVF, respectively, with a higher proportion of PVFs having a classic measles presentation and severe disease than SVFs. DISCUSSION: Breakthrough measles cases tended to have milder disease with less complications. A small proportion of breakthrough infections were due to PVF than SVF. It is critical to maintain high measles-mumps-rubella vaccination coverage in the United States to prevent serious measles illnesses. |
Association of mRNA COVID-19 vaccination and reductions in Post-COVID Conditions following SARS-CoV-2 infection in a US prospective cohort of essential workers
Mak J , Khan S , Britton A , Rose S , Gwynn L , Ellingson KD , Meece J , Feldstein LR , Tyner H , Edwards LJ , Thiese MS , Naleway A , Gaglani M , Solle N , Burgess JL , Lamberte JM , Shea M , Hunt-Smith T , Caban-Martinez A , Porter C , Wiegand R , Rai R , Hegmann KT , Hollister J , Fowlkes A , Wesley M , Philips AL , Rivers P , Bloodworth R , Newes-Adeyi G , Olsho LEW , Yoon SK , Saydah S , Lutrick K . J Infect Dis 2025 231 (3) 665-676 ![]() ![]() ![]() BACKGROUND: Data are limited on whether vaccination reduces post COVID conditions (PCCs) risk after less severe nonhospitalized coronavirus disease 2019 (COVID-19). This study assessed whether COVID-19 vaccination protected against PCCs in persons with mild initial infections during Delta and Omicron variant predominance. METHODS: This study utilized a case-control design, nested within the HEROES-RECOVER cohort. Participants aged ≥18 years with test-confirmed severe acute respiratory syndrome coronavirus disease 2 (SARS-CoV-2) between 28 June 2021 and 14 September 2022 were surveyed for PCCs, defined by symptoms lasting >4 weeks after initial infection. Cases self-reported PCCs and controls self-reported no PCCs. The exposure was messenger RNA (mRNA) COVID-19 vaccination (2 or 3 monovalent doses). Odds of PCCs among vaccinated and unvaccinated persons were compared with logistic regression. RESULTS: Of 936 participants, 23.6% reported PCCs and 83.2% were vaccinated. Participants who received 3 vaccine doses had lower odds of PCC-related gastrointestinal, neurological, and other symptoms compared to unvaccinated participants (adjusted odds ratio [95% confidence interval]: 0.37 [.16-.85], 0.56 [.32-.97], and 0.48 [.25-.91], respectively). CONCLUSIONS: COVID-19 vaccination protected against development of PCCs among persons with mild infection during both Delta and Omicron variant predominance, supporting vaccination as an important PCCs prevention tool. |
Association between county-level social vulnerability and CDC-funded HIV testing program outcomes in the United States, 2020-2022
Song W , Mulatu MS , Crepaz N , Wang G , Patel D , Xia M , Essuon A . J Acquir Immune Defic Syndr 2025 98 (5) 450-464 ![]() BACKGROUND: Community-level social vulnerabilities may affect HIV outcomes. This analysis assessed the association between county-level social vulnerability and Centers for Disease Control and Prevention (CDC)-funded HIV testing program outcomes. SETTING: HIV testing data from 60 state and local health departments and 119 community-based organizations were submitted to CDC during 2020-2022. METHODS: HIV testing data were combined with the county-level Minority Health Social Vulnerability Index, which measures economic, medical, and social vulnerability. We calculated absolute and relative disparity measures for HIV testing program outcomes (ie, HIV positivity, linkage to HIV medical care, interview for partner services, referral to preexposure prophylaxis providers) between high and low social vulnerability counties. We compared differences in HIV testing program outcomes by demographic factors and test site type. RESULTS: The majority (85.8%) of the 4.9 million tests were conducted in high social vulnerability counties. HIV positivity (1.1%) and linkage to medical care after a new diagnosis (77.5%) were higher in high social vulnerability counties. However, interview for partner services after a new diagnosis (72.1%) and referrals to preexposure prophylaxis providers among eligible HIV-negative persons (48.1%) were lower in high social vulnerability counties. Additionally, the relative disparity in HIV testing program outcomes varied by demographic factors and test site type. CONCLUSIONS: CDC-funded HIV testing programs reach the most vulnerable communities. However, testing outcomes vary by community vulnerability, demographic factors, and test site type. Continued monitoring of the relationship between county-level social vulnerability and HIV testing program outcomes would guide HIV testing efforts and allocate resources effectively to achieve the national goal of ending the HIV epidemic. |
Influenza vaccine-averted illness in Chile, Guyana, and Paraguay during 2013-2018: A standardized approach to assess the value of vaccination
Jara JH , Loayza S , Nogareda F , Couto P , Descalzo MA , Chard AN , Olivares Barraza MF , Vergara Mallegas N , Fasce RA , Von Horoch M , Battaglia S , Penayo E , Dominguez CM , Vazquez C , Escalada R , Woolford J , Michel F , Chacon R , Fowlkes A , Castro L , Velandia-Gonzalez M , Rondy M , Azziz-Baumgartner E , Tempia S , Salas D . J Infect Dis 2025 231 S133-s143 ![]() BACKGROUND: To better establish the value of vaccination against influenza viruses, we estimated vaccine-averted influenza illnesses among young children and older adults in Chile, Guyana, and Paraguay. METHODS: We gathered country- and target population-specific data on monthly influenza hospitalizations, vaccine coverage, and vaccine effectiveness from surveillance records and immunization registries during 2013-2018. We applied a static compartmental model to estimate differences in the number influenza-associated respiratory disease events (symptomatic nonhospitalized illnesses, medically attended illnesses, hospitalizations) in the presence and absence of influenza vaccination programs. RESULTS: Between 2013 and 2018, vaccinating 68% of children aged 6-23 months in Chile averted an annual mean of 14 617 nonhospitalized, 9426 medically attended, and 328 hospitalized influenza illnesses; vaccinating 28% of children aged 6-23 months in Paraguay averted 1115 nonhospitalized, 719 medically attended, and 25 hospitalized influenza illnesses. Vaccinating 59% of older adults in Chile averted an annual mean of 83 429 nonhospitalized, 37 079 medically attended, and 1390 hospitalized influenza illnesses; vaccinating 36% of older adults in Paraguay averted an annual mean of 3932 nonhospitalized, 1748 medically attended, and 66 hospitalized influenza illnesses. In Guyana, a hypothetical campaign vaccinating 30% of children aged <5 years could have prevented an annual 1496 nonhospitalized, 971 medically attended, and 10 hospitalized influenza illnesses. Vaccinating 30% of adults aged ≥65 years could have prevented 568 nonhospitalized, 257 medically attended, and 10 hospitalized influenza illnesses. CONCLUSIONS: Influenza vaccination averted tens of thousands of illnesses and thousands of hospitalizations in Chile and Paraguay; influenza vaccination could have had a proportional benefit in Guyana. |
A comparative analysis of universal and sentinel surveillance data for coronavirus disease 2019: Insights from Argentina, Chile, and Mexico (2020-2022)
Redondo-Bravo L , Zureick K , Voto C , Molina Avendaño X , Flores-Cisneros L , Fowlkes A , Iummato LE , Giovacchini C , Olivares Barraza MF , Rodriguez Ferrari P , Gutiérrez-Vargas R , Zaragoza-Jiménez CA , García-Rodríguez G , López-Gatell H , Rodríguez Á , Couto P , Rondy M , Vicari AS . J Infect Dis 2025 231 S114-s122 ![]() BACKGROUND: In 2020, countries implemented universal surveillance to detect and monitor severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cases. Although crucial for early monitoring efforts, universal surveillance is resource intensive. To understand the implications of transitioning from universal to sentinel surveillance for monitoring SARS-CoV-2 transmissibility, morbidity and mortality, and disease seriousness, we compared measures of SARS-CoV-2 reported from both surveillance strategies in Argentina, Chile, and Mexico. METHODS: We obtained weekly case counts in Argentina, Chile, and Mexico, in periods when both universal and sentinel surveillance were ongoing. To assess the countries' surveillance strategies, we measured the proportion of total sites that were included in sentinel surveillance. We compared 8 measures of SARS-CoV-2 transmissibility, morbidity and mortality, and disease seriousness between sentinel and universal surveillance and assessed the correlation between the 2 strategies for the 8 measures. Pearson and Spearman correlation was classified as very strong (rs = 0.8-1.0), strong (rs = 0.60-0.79), moderate (rs = 0.50-0.59), or poor (r < 0.50). RESULTS: The proportion of total sites included in sentinel surveillance was 5.8% for Argentina, 1.1% for Chile, and 7.6% for Mexico. A total of 21 measures were calculated (8 for Mexico, 8 for Chile, and 5 for Argentina). Of these, 17 showed consistency between the 2 surveillance strategies, with strong or very strong correlations (r = 0.66-0.99): all 8 measures for Mexico, 6 of 8 measures for Chile, and 3 of 5 measures for Argentina. Each country had ≥1 measure reflecting transmissibility and ≥1 reflecting morbidity and mortality for which the correlation was strong or very strong. Chile and Mexico also had ≥1 measure of disease seriousness for which the correlation was strong. CONCLUSIONS: Our findings suggest that the integration of SARS-CoV-2 into national sentinel surveillance can yield information comparable to that provided by nationwide universal surveillance for measures related to SARS-CoV-2 transmissibility, morbidity and mortality, and seriousness of disease. |
Fatal case of splash pad-associated naegleria fowleri meningoencephalitis - Pulaski County, Arkansas, September 2023
Dulski TM , Montgomery F , Ramos JM , Rosenbaum ER , Boyanton BL Jr , Cox CM , Dahl S , Kitchens C , Paul T , Kahler A , Roundtree A , Mattioli M , Hlavsa MC , Ali IK , Roy S , Haston JC , Patil N . MMWR Morb Mortal Wkly Rep 2025 74 (10) 167-172 ![]() A fatal case of primary amebic meningoencephalitis (PAM), an infection caused by Naegleria fowleri, was diagnosed in Arkansas in a young child in September 2023. A public health investigation was completed, with epidemiologic, laboratory, and environmental data suggesting that a splash pad (an interactive water play venue that sprays or jets water on users and has little or no standing water) with inadequately disinfected water was the most likely site of the patient's N. fowleri exposure. This case is the third occurrence of splash pad-associated PAM reported in the United States; all three cases involved inadequately disinfected water. PAM should be considered in patients with acute meningoencephalitis and a history of recent possible exposure to fresh water, including treated recreational water (e.g., in splash pads or pools), via the nasal passages. Proper design, construction, operation, and management of splash pads can help prevent illnesses, including N. fowleri infections. Increased awareness, collaboration, and communication among clinicians, hospitals, laboratories, CDC, health departments, the aquatics sector, and the public can help support N. fowleri infection identification, treatment, prevention, and control efforts. |
Influenza-associated hospitalization rates by underlying conditions, 2016-17 to 2019-20: A retrospective cohort study
Frutos AM , Tenforde MW , Sundaresan D , Naleway AL , Irving SA , DeSilva MB , Kharbanda AB , Ong TC , Rao S , Zheng K , Gohil SK , Ball SW , Fink RV , Reed C , Garg S , Bozio CH . J Infect Dis 2025 ![]() BACKGROUND: Various underlying medical conditions (UMCs) elevate the risk of influenza-associated hospitalization. We evaluated how these rates changed by type and number of UMCs. METHODS: Retrospective cohorts were constructed among adult members of two health systems aged ≥18 years with prior healthcare utilization. Across the 2016-17 to 2019-20 seasons, we estimated influenza-associated hospitalization rates by type and number of UMCs. Hospitalizations were defined using discharge diagnoses or laboratory confirmation. We calculated adjusted rate ratios (aRR) using Poisson regression controlling for site, season, and demographic characteristics. We used causal mediation to estimate the effect of UMCs on influenza-associated hospitalization accounting for influenza vaccination status. RESULTS: Among 870,888 cohort members, 1,403 were hospitalized with influenza at least once within a season across four seasons. Compared to those without, the aRR for influenza-associated hospitalization was highest for individuals with congestive heart failure (4.2, 95% CI: 3.6-4.9). The aRRs also increased with each additional UMCs compared to those with no UMCs. The effect of UMCs on influenza-associated hospitalizations was higher when not mediated by vaccination status; for those with ≥4 UMCs compared to no UMCs, rates were about 60% higher. CONCLUSION: The burden of baseline medical conditions is associated with higher rates of influenza-associated hospitalization. Among those with varying types and number of UMCs, if vaccination prevalence had been lower than observed, influenza-associated hospitalization rates would have been higher. These findings highlight the importance of preventive medical care and annual influenza vaccination in reducing influenza-associated hospitalizations, particularly for individuals at high-risk. |
Leveraging implementation science to end the HIV epidemic in the United States: Progress and opportunities for federal agencies
Gordon C , Koenig LJ , Psihopaidas D , Refsland E , Mandt R . J Acquir Immune Defic Syndr 2025 98 e10-e16 ![]() Implementation science has emerged and matured as an essential field for HIV treatment and prevention, designed to bridge the gap between research and practice by identifying opportunities to overcome barriers to implementation of effective interventions, and to accelerate the replication and scale-up of HIV care innovations. In this article, we describe activities and collaborations among the Centers for Disease Control and Prevention, the Health Resources and Services Administration, and the National Institutes of Health to optimize the impact of national federal funding opportunities aimed at identifying effective and replicable HIV care and prevention interventions, improving HIV health outcomes, and reducing HIV incidence in the U.S. These activities are outlined in the context of the Ending the HIV Epidemic in the U.S. Initiative, which was enacted across U.S. Department of Health and Human Services agencies, providing new funding and outlining an operational plan to further guide federal agencies in their specific roles and funding areas.In describing these activities and opportunities, we aim to demonstrate how implementation science is being increasingly leveraged to accelerate progress towards ending HIV through scale-up and dissemination efforts. Continued collaboration through federal implementation science will be instrumental in reaching Ending the HIV Epidemic goals. |
Rural and urban trends in HIV diagnoses and care outcomes among persons with HIV attributed to injection drug use in the U.S., 2016-2022
Keino BC , Thomson A , Li J , Hess KL . Ann Epidemiol 2025 ![]() PURPOSE: An increase in injection drug use (IDU) has placed new populations at risk for HIV. Understanding the spatial and temporal patterns of HIV diagnoses and care outcomes is crucial to identify gaps in care for people who inject drugs (PWID). METHODS: We analyzed CDC's National HIV Surveillance System (NHSS) data from 2016 to 2022 to examine regional trends and rural-urban differences in linkage to HIV care within one month and viral suppression within six months of diagnosis among individuals aged 13 and older with HIV attributed to IDU. Rural-urban populations were defined using US Department of Agriculture-Economic Research Service (USDA-ERS) Rural-Urban Continuum Codes (RUCC), and trends were assessed using estimated annual percentage change (EAPC). RESULTS: From 2016 to 2022, HIV diagnoses attributed to IDU increased in large rural counties and small to medium urban counties but linkage to care and viral suppression remained unchanged in these areas. Conversely, diagnoses in large urban counties declined while linkage to care and viral suppression increased. CONCLUSIONS: These findings highlight disparities in HIV diagnoses, linkage to care, and viral suppression across rural and urban areas, emphasizing the need to address these gaps to improve care for PWID and inform public health policies. |
Tuberculosis incidence and outcomes among older New Yorkers
Kyaw NTT , Silin M , Trieu L , Ahuja SD , Foerster S , Jordan HT . Open Forum Infect Dis 2025 12 (3) ofaf059 ![]() BACKGROUND: There were limited data on tuberculosis (TB) epidemiology and outcomes among older adults in the United States. We analyzed TB epidemiology and outcomes among New York City residents to identify opportunities for prevention and improved outcomes among older adults. METHODS: We used New York City TB surveillance data to describe TB incidence, patient characteristics, and treatment outcomes comparing older (≥65 years) and younger (18-64 years) adults. Cox proportional hazard models were used to assess characteristics associated with death. RESULTS: During 2001-2022, overall TB incidence declined from 18 to 7 cases per 100 000 population. Of 5577 TB cases during 2011-2020, 1360 (24%) were among older adults. Among older adults with TB, 86% were born outside the United States (median of 24 years in United States at diagnosis), 8% had lived in long-term care facilities, and 5% died before starting TB treatment. Hazard ratio (HR) of death among adults aged 65-74 years during TB treatment was 7.19 (95% confidence interval [CI], 4.56-11.34) compared to adults aged 18-44 years. Among older adults, those with a history of living in long-term care (HR, 2.57; 95% CI, 1.74-3.80) or hepatitis B or C (HR, 1.86; 95% CI, 1.09-3.15) had a higher hazard of death during treatment. CONCLUSIONS: Efforts to prevent TB among older New Yorkers by identifying and treating latent TB could focus on long-term care facility residents. Educating providers regarding early diagnosis of TB and comorbidities associated with poor treatment outcomes might help prevent onward transmission and TB-associated mortality in this age group. |
Operation triple zero: Implementation, processes, and outcomes of an asset-based approach to achieving viral suppression among adolescents and young persons living with HIV in Kenya, 2017-2021
Mutisya I , Waruru A , Ondondo R , Omoto L , Hrapcak S , Gross J , Carpenter D , Odingo G , Kimanga D , Njuguna S , Muhenje O , Ngugi E , Katana A , Ng'ang'a L . J Adolesc Health 2025 ![]() PURPOSE: The 2018 Kenya Population-based HIV Impact Assessment revealed gaps in HIV care among adolescents and young people living with HIV (AYPLHIV) aged 10-24 years, with only 70.6% aware of their status, of these, 93.1% on antiretroviral therapy (ART), and 79.2% of those on treatment had achieved viral load suppression (VLS). Operation Triple Zero (OTZ) aims to address these gaps by fostering intrinsic motivation in AYPLHIV to achieve good health outcomes, emphasizing zero missed appointments, zero missed medication, and zero viral load. We examine clinical outcomes of VLS, ART adherence, and retention among AYPLHIV aged 10-24 enrolled in OTZ from 2017 to 2021. METHODS: Data from 20 early adopter OTZ sites were analyzed for ART adherence, retention, viral load testing, and VLS. We compared demographic and clinical characteristics at enrollment and end line by sex, using Pearson's chi-square test for categorical variables, McNemar chi-square test, and Wilcoxon rank-sum for baseline versus end-line comparisons. RESULTS: Of 1,569 AYPLHIV enrolled in OTZ, 1,372 (87.4%) had complete records. The median age at OTZ enrollment was 12 years (interquartile range: 14-16). VLS improved from 72.7% to 88.5% (p < .001), and 96% of AYPLHIV were retained on ART. Among virally suppressed AYPLHIV at baseline (n = 958), 92.4% sustained VLS (91.9% females, 92.9% males), notably 100% among those on once-a-day dolutegravir or atazanavir. Re-suppression rate for viremic AYPLHIV at baseline (n = 360) was 78.3%. Satisfactory adherence correlated with higher re-suppression rates. DISCUSSION: OTZ implementation led to improved HIV treatment outcomes among AYPLHIV, contributing to sustained epidemic control efforts complementing other interventions. |
Varicella-zoster virus testing in clinical practice in the U.S., 2016-2023
Raparti L , Leung J , Anderson TC , Wakeman B , Beard S , Baca S , Egwuogu H , Guevara OR , Raykin J , Oliver SE , Marin M . Am J Prev Med 2025 ![]() INTRODUCTION: Varicella-zoster virus (VZV) testing is increasingly needed for assessing immunity and diagnosis in the varicella vaccination era. VZV-specific immunoglobulin G (IgG) is recommended when assessing immunity; real-time polymerase chain reaction (PCR) is recommended for varicella or herpes zoster diagnosis. The study objective was to describe VZV serologic and virologic testing in U.S. clinical practice. METHODS: Patients with serologic (IgG, IgM) or virologic (PCR, culture) VZV testing were identified in five administrative data sources (∼11-100 million enrollees; 2016-2023). Descriptive analyses were used to examine VZV testing frequency, patient characteristics, and rates by test type. The top 20 diagnostic codes associated with VZV test type were used as a proxy for reason for testing. RESULTS: Across data sources, the highest proportion of VZV testing was for IgG (43%-92%); most was in females (79%-82%) and those aged 20-39 years (62%-70%). Rates of serologic testing were 50-60/10,000 persons. Frequency of VZV virologic testing was considerably lower; PCR testing rates were ∼1/10,000 persons. Diagnostic codes associated with IgG or virologic testing were primarily categorized as routine care or acute illness, respectively. IgM testing was up to 11% of tests, despite not being recommended for screening or diagnostic purposes. CONCLUSIONS: VZV serologic testing rates were 50-60 times higher than PCR. Serologic testing was more common among females and young adults, likely due to screening. Most VZV testing appeared relevant to clinical management; however, inappropriate IgM testing was identified. Appropriate testing is important to guide clinical and public health management for varicella and herpes zoster. |
Use of different genotyping methods to estimate TB transmission in the United States, 2020-2021
Schildknecht KR , Cowen LS , Posey JE , Talarico S , Haddad MB , Wortham JM , Kammerer JS . Int J Tuberc Lung Dis 2025 29 (4) 193-195 ![]() ![]() |
Newly reported chronic hepatitis C among adults - Alaska, 2016-2023
Scobie HM , Allison J , Masters N , Toomey M , Blake I , Johnston JM , Teshale E , Lawrence R , Ohlsen E , Bruden D , Fischer M , McLaughlin J . MMWR Morb Mortal Wkly Rep 2025 74 (10) 161-166 ![]() Hepatitis C virus is a leading cause of chronic liver disease, hepatocellular carcinoma, and liver-related death and is targeted for global elimination as a public health threat by 2030. Universal screening is recommended for all adults aged ≥18 years and pregnant women during each pregnancy; periodic risk-based screening also is recommended. Persons with current infection should be linked to antiviral treatment, which usually results in a virologic cure within 8-12 weeks. To assess progress toward elimination, epidemiologic trends in newly reported chronic hepatitis C cases were assessed among adult Alaska residents during 2016-2023. Overall, 5,352 confirmed chronic hepatitis C cases were newly reported among adults aged ≥18 years. The average annual rate (cases per 100,000 population) was 121 and decreased a relative 30% from 142 during 2016-2019 to 99 during 2020-2023. Statistically significant decreases occurred for most groups. Groups with higher average rates included males, adults aged 18-39 years, residents of rural areas, and American Indian or Alaska Native persons. Hepatitis C surveillance can help monitor trends in health outcomes and identify groups needing tailored testing and treatment interventions toward hepatitis C elimination. |
South-East Asia regional neglected tropical disease framework: improving control of mycetoma, chromoblastomycosis, and sporotrichosis
Smith DJ , Soebono H , Parajuli N , Grijsen ML , Cavanaugh AM , Chiller T , Pudasaini P , Barros TC , Chakrabarti A . Lancet Reg Heal Southeast Asia 2025 35 ![]() Mycetoma, chromoblastomycosis, and sporotrichosis are fungal neglected tropical diseases (NTDs) recognized by the World Health Organization. These implantation diseases cause substantial morbidity, disability, decreased quality of life, and can lead to long-term complications including tissue fibrosis, skin cancer, and amputation. The 2024–2030 South-East Asia Regional NTD Strategic Framework includes mycetoma but neglects the full extent of mycetoma endemicity in the region. Furthermore, the framework excludes chromoblastomycosis and sporotrichosis. We describe the data demonstrating fungal NTDs being of public health concern in this region and more widely distributed than acknowledged in the framework. Additionally, we propose modifications to public health interventions and services for fungal NTDs including an active case search approach through community health workers. Severe disease from fungal NTDs in South-East Asia can be eliminated by improving burden data quality, early diagnosis, accessible treatment, and integration with other common and neglected skin diseases. © 2025 |
COVID-19 symptomatic community illness, hospitalization, and death burden across all ages - New South Wales, Australia, May 2021-July 2022
Sumner KM , Carlson S , Elton B , Butler M , Amin J , Rolfes MA , Reed C , Iuliano AD , Muscatello DJ , Dalton C . BMC Public Health 2025 25 (1) 1177 ![]() BACKGROUND: Coronavirus disease 2019 (COVID-19) burden is difficult to quantify with cases missed by surveillance systems. During COVID-19 Delta and Omicron BA.1-5 periods, we assessed the COVID-19 burden in New South Wales (NSW), Australia, from May 2021-July 2022 using a participatory surveillance system of self-reported respiratory disease and a database of people seeking healthcare. METHODS: To estimate community illness burden, we adjusted the NSW age-stratified non-case population by reported severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) percent positive and acute respiratory illness (ARI) rates. Hospitalization and death burden were estimated by adjusting reported rates to the NSW population and by the proportion of COVID-19 admissions attributable to COVID-19 illness. Burden estimates were compared to reported case counts. RESULTS: From May 2021-July 2022, an estimated 3,450,516 (95%CI: 2,847,355-4,119,472) symptomatic community ARI illnesses, 24,684 (95%CI: 20,714-29,144) hospitalizations, and 4,638 (95% CI: 3,263-6,049) deaths were attributable to COVID-19 in NSW. Reported cases (3,039,239) were 14% lower than the estimated symptomatic community illness burden but within the estimate's 95% confidence interval. Overall, 0.7% of symptomatic community illnesses resulted in hospitalization and 0.1% resulted in death. CONCLUSIONS: Estimated symptomatic case hospitalization and fatality risk could be used for COVID-19 modelling and forecasting. |
Microplanning improves stakeholders' perceived capacity and engagement to implement lymphatic filariasis mass drug administration
Worrell CM , Brant TA , Javel A , Denis E , Fayette C , Monestime F , Knowles E , Bennett C , Utzinger J , Odermatt P , Lemoine JF . PLoS Negl Trop Dis 2025 19 (3) e0012105 ![]() BACKGROUND: Achieving adequate mass drug administration (MDA) coverage for lymphatic filariasis is challenging. We sought to improve stakeholder engagement in MDA planning and increase subsequent MDA coverage through a series of microplanning workshops. METHODOLOGY: Prior to the 2018 MDA, Haiti's Ministry of Public Health and Population (MSPP) and partners conducted 10 stakeholder microplanning workshops in metropolitan Port-au-Prince. The objectives of the workshops were to identify and address gaps in geographic coverage of supervision areas (SAs); review past MDA performance and propose strategies to improve access to MDA; and review roles and responsibilities of MDA personnel through increased stakeholder engagement. Retrospective pre-testing was employed to assess the effectiveness of the workshops. Participants used a 5-point scale to rank their understanding of past performance, SA boundaries, roles and responsibilities, and their perceived engagement by MSPP. Participants simultaneously ranked their previous year's attitudes and their attitudes about MDA following the 2-day microplanning workshop. Changes in pre- and post-scores were analyzed using Wilcoxon signed-rank tests. PRINCIPAL FINDINGS: A total of 356 stakeholders across five communes participated in the workshops. Participants conducted various planning activities, including revising SA boundaries to ensure full geographic reach of MDA, proposing or validating social mobilization strategies, and proposing other MDA improvements. Compared with previous year rankings, the workshops increased participant understanding of past performance by 1.34 points (standard deviation [SD] = 1.05, p <0.001); SA boundaries by 1.14 points (SD = 1.30; p <0.001); their roles and responsibilities by 0.71 points (SD = 0.95, p <0.001); and sense of engagement by 1.03 points (SD = 1.08, p <0.001). Additionally, compared with 2017, drug coverage increased in all five communes during the 2018 MDA. |
Human cases of highly pathogenic avian influenza A(H5N1) - California, September-December 2024
Zhu S , Harriman K , Liu C , Kraushaar V , Hoover C , Shim K , Brummitt SI , Limas J , Garvey K , McNary J , Gao NJ , Ryder R , Stavig B , Schapiro J , Morales C , Wadford DA , Howard H , Heffelfinger J , Campagna R , Iniguez-Stevens E , Gharibi H , Lopez D , Esbenshade L , Ptomey P , Trivedi KK , Herrera JA , Locke J , Moss N , Rzucidlo P , Hernandez K , Nguyen M , Paul S , Mateo J , Del Carmen Luna C , Chang Y , Rangel M , DeLeon K , Masood A , Papasozomenos T , Moua P , Reinhart K , Kniss K , Davis CT , Kirby MK , Pan E , Murray EL . MMWR Morb Mortal Wkly Rep 2025 74 (8) 127-133 ![]() ![]() Persons who work closely with dairy cows, poultry, or other animals with suspected or confirmed infection with highly pathogenic avian influenza (HPAI) A(H5N1) viruses are at increased risk for infection. In September 2024, the California Department of Public Health was notified of the first human case of HPAI A(H5N1) in California through monitoring of workers on farms with infected cows. During September 30-December 24, 2024, a total of 38 persons received positive test results for HPAI A(H5N1) viruses in California; 37 were dairy farm workers with occupational exposure to sick cows, and one was a child aged <18 years with an undetermined exposure, the first pediatric HPAI A(H5N1) case reported in the United States. All patients had mild illness. The identification of cases associated with occupational exposure to HPAI A(H5N1) viruses on dairy farms highlights the continued risk for persons who work with infected animals. The pediatric case was identified through routine surveillance. Given recent increases in the prevalence of HPAI A(H5N1) viruses among some animal populations, public health agencies should continue to investigate cases of HPAI A(H5N1) in humans as part of control measures, pandemic preparedness, to identify concerning genetic changes, and to prevent and detect potential human-to-human transmission of the virus. To date, no human-to-human transmission of HPAI A(H5N1) virus has been identified in the United States. |
The burden of all-cause mortality following influenza-associated hospitalizations, FluSurv-NET, 2010-2019
O'Halloran AC , Millman AJ , Holstein R , Olsen SJ , Cummings CN , Chai SJ , Kirley PD , Alden NB , Yousey-Hindes K , Meek J , Openo KP , Fawcett E , Ryan PA , Leegwater L , Henderson J , McMahon M , Lynfield R , Angeles KM , Bleecker M , McGuire S , Spina NL , Tesini BL , Gaitan MA , Lung K , Shiltz E , Thomas A , Talbot HK , Schaffner W , Hill M , Reed C , Garg S . Clin Infect Dis 2025 80 (3) e43-e45 ![]() BACKGROUND: While the estimated number of US influenza-associated deaths is reported annually, detailed data on the epidemiology of influenza-associated deaths, including the burden of in-hospital vs post-hospital discharge deaths, are limited. METHODS: Using data from the 2010-2011 through 2018-2019 seasons from the Influenza Hospitalization Surveillance Network, we linked cases to death certificates to identify patients who died from any cause during their influenza hospital stay or within 30 days post discharge. We described demographic and clinical characteristics of patients who died in the hospital vs post discharge and characterized locations and causes of death (CODs). RESULTS: Among 121 390 cases hospitalized with laboratory-confirmed influenza over 9 seasons, 5.5% died; 76% of deaths were in patients aged ≥65 years, 71% were non-Hispanic White, and 34% had 4 or more underlying medical conditions. Among all patients with an influenza-associated hospitalization who died, 48% of deaths occurred after hospital discharge; the median number of days from discharge to death was 9 (interquartile range, 3-19). Post-discharge deaths more often occurred in older patients and among those with underlying medical conditions. Only 37% of patients who died had "influenza" as a COD on their death certificate. Influenza was more frequently listed as a COD among persons who died in the hospital compared with cardiovascular disease among those who died after discharge. CONCLUSIONS: All-cause mortality burden is substantial among patients hospitalized with influenza, with almost 50% of deaths occurring within 30 days after hospital discharge. Surveillance systems should consider capture of post-discharge outcomes to better characterize the impact of influenza on all-cause mortality. |
Prevalence of transfusion transmitted infections by mode of donation and remuneration status among blood donors in Georgia, 2018-2023
Shermadini K , Bloch EM , Shadaker S , Alkhazashvili M , Chitadze N , Surguladze S , Tskhomelidze I , Getia V , Adamia E , Tohme RA , Gabunia T . Transfus Apher Sci 2025 64 (3) 104110 ![]() Global reform of blood transfusion services is underway in the country of Georgia. New legislation mandates exclusive collection of blood from non-remunerated blood donors in Georgia by July 2025. Retrospective data (2018-2023) from the National Blood Donor Registry were analyzed. The prevalence was calculated for human immunodeficiency virus (HIV) antigen/antibody (Ag/Ab), hepatitis C virus antibody (anti-HCV), hepatitis B surface antigen (HBsAg). Results were stratified by remuneration status and mode of donation. Descriptive analysis was performed to elucidate differences in positivity by year and donor type. During 2018-2023, there were a total of 548,530 donations from 221,492 blood donors in Georgia; 68.3 % of donors were male and the median age was 34 years (interquartile range: 2644). Overall, 17.0 % were paid, 24.9 % were replacement, 47.4 % were voluntary non-remunerated blood donors (VNRBD), and 10.7 % had ≥ 2 donations of varying remuneration type. Paid donors had an average of 2.5 donations per year, compared to 1.0 for replacement, and 1.1 for VNRBDs. During 2018-2023, the proportions of paid donors decreased (38.8-22.1 %); the proportions of replacement (19.1-26.0 %) and VNRBDs (38.7-48.3 %) increased. Among first-time donors, prevalence decreased during 2018-2023 for anti-HCV (2.0-0.9 %) but were stable for HBsAg (range: 1.9 %-2.1 %) and anti-HIV (range: 0.1 %-0.2 %). Among repeat donors, prevalence of anti-HCV decreased (from 0.3 % to 0.2 %) while rates were stable for anti-HIV (0.04 %-0.1 %), and HBsAg (0.1 % in all years). The findings underscore the importance of donor retention in concert with efforts to attain exclusive VNRBD. |
Notes from the field: Fatal acanthamoeba encephalitis in a patient who regularly used tap water in an electronic nasal irrigation device and a continuous positive airway pressure machine at home - New Mexico, 2023
Haston JC , Ali IK , Roy S , Roundtree A , Hofstetter J , Pierson S , Helmrich E , Torres P , Lockey K , Martines RB , Mattioli M . MMWR Morb Mortal Wkly Rep 2025 74 (10) 179-180 ![]() |
Forest terpenes and stress: Examining the associations of filtered vs. non-filtered air in a real-life natural environment
Levy CM , Riederer AM , Simpson CD , Gassett AJ , Gilbert AJ , Paulsen MH , Silva LK , Bhandari D , Newman CA , Blount BC , Kahn PH Jr , Bratman GN . Environ Res 2025 121482 ![]() Human health may benefit from exposure to a class of biogenic volatile organic compounds (BVOCs) consisting of isoprene units, known as terpenes. In this double-blind, randomized crossover trial, participants sat in a forest for two 60-minute sessions, one in which terpenes were filtered out of the ambient air they breathed, and another in which they were not, separated by a minimum of an eight-day washout period. The primary outcome was the high frequency (HF) component of heart rate variability (HRV; measured continuously). Secondary outcomes included skin conductance levels (SCL) (measured continuously), self-reported stress and affect (measured every 20 minutes), blood pressure, heart rate, cortisol and inflammatory cytokines (measured before and after sessions). Serum concentrations of terpenes (measured before and after sessions) were also assessed to investigate the association of absorbed dose with these outcomes. We did not observe a significant association of filter condition with most outcomes; although the trends for affect, systolic blood pressure, cortisol, TNF-α, and CRP were all in the hypothesized direction. We did observe a significant association with interleukin-6, which was -0.19 pg/mL lower in the terpenes-on vs. terpenes-off condition, adjusted for baseline (95% CI: -0.35, -0.03); and SCL over the session as a whole. A sensitivity analysis of the subset of data from participants who completed both conditions supports these findings and revealed additional significant associations with SCL (95% CI: -0.35, -0.02); and TNF-α (95% CI: -2.63, -0.01). To our knowledge, this is the first RCT to filter ambient air from terpenes during forest contact. |
Awareness of wildfire smoke among U.S. Adults with and without asthma
Mirabelli MC , Dowling TC , Freelander L , Pennington AF , Damon SA . J Asthma 2025 1-20 ![]() OBJECTIVE: To describe awareness of ambient wildfire smoke among U.S. adults with and without asthma. METHODS: We analyzed data from the summer wave of the 2021 ConsumerStyles survey, a nationally representative survey of 4,085 U.S. adults. Respondents self-reported their asthma status and awareness of wildfire smoke where they lived in the past 12 months. We linked survey responses by zip code of residence with satellite-detected wildfire smoke plume data that estimated the daily maximum smoke plume density over the preceding year. We estimated associations between asthma status and awareness of wildfire smoke across categories of maximum smoke plume density and days with medium- or heavy-density smoke as prevalence ratios (PRs) with 95% confidence intervals (CIs) using predicted marginal probabilities from logistic regression models. RESULTS: Over 98% of the estimated population of U.S. adults lived in a zip code affected by ≥1 day of medium- or heavy-density wildfire smoke, which occurred on an average of 16 days in the past year. Awareness of wildfire smoke was reported by 19% of U.S. adults and was higher among adults with than without asthma (PR: 1.25; 95% CI: 1.01, 1.55), including in zip codes affected by heavy-density smoke (PR: 1.30, 95% CI: 1.04, 1.63) and with 22 or more days of medium- to heavy-density smoke (PR: 1.22, 95% CI: 1.01, 1.47). CONCLUSIONS: Although awareness of wildfire smoke was higher among U.S. adults with than without asthma, low percentages of awareness overall indicate a need for health communication about wildfire smoke and its health risks. |
Urinary concentrations of early and mid-pregnancy parabens and gestational diabetes: A nested case-control study within the PETALS cohort
Peterson AK , Zhu Y , Feng J , Calafat AM , Hedderson MM , Alexeeff SE , Ferrara A . Sci Total Environ 2025 974 179253 ![]() Parabens are widely used preservatives with endocrine-disrupting properties, but their role in glucose metabolism during pregnancy is unclear. This study examines prospective associations between urinary concentrations of four parabens in early and mid-pregnancy and gestational diabetes (GDM). A matched case-control study nested within a diverse longitudinal pregnancy cohort (PETALS) with universal GDM screening matched GDM cases to two controls (111 cases; 222 controls). Urine samples collected 2015-2017 in early (14 ± 2.3 weeks) and mid-pregnancy (20 ± 2.4 weeks) were analyzed for paraben concentrations with mass spectrometry. Area-under-the-time-concentration-curve (AUC) assessed cumulative exposure. Conditional logistic regression models evaluated associations between paraben concentrations and GDM, adjusting for covariates. We a priori examined effect modification by Asian/Pacific Islander (A/PI) race/ethnicity due to the case-control matching and GDM prevalence highest among A/PI. Participants were 31 ± 5 years old and 40 % A/PI, 33 % Hispanic, 14 % White and 9 % Black. Methylparaben and propylparaben had >94 % detection, while ethylparaben and butylparaben ranged from 22 %-51 %. Paraben exposure was not associated with GDM overall. Among A/PI, higher methylparaben concentrations exhibited higher odds of GDM: early-pregnancy OR 1.14 per IQR (95 % CI: 0.89,1.45) and AUC 1.07 (0.89,1.30) compared to non-A/PI (early-pregnancy 0.81 [0.62,1.06] and AUC 0.70 [0.44,1.12]; P(interaction) = 0.01 and 0.03, respectively). A/PI mid-pregnancy ethylparaben exposure (detectable vs non-detectable) was linked to higher GDM odds (2.00 [0.84,4.76] vs. non-A/PI 0.47 [0.17,1.27]; P(interaction) = 0.04) as was mid-pregnancy propylparaben exposure (Tertile 2 vs. 1: 3.67 [1.21,11.1] vs. non-A/PI 0.70 [0.22, 2.25]; P(interaction) = 0.04). Although overall paraben exposure was not associated with GDM, interactions by A/PI race/ethnicity suggested potential increased odds of GDM related to propylparaben, methylparaben, and ethylparaben exposure. Future studies should explore paraben exposure in diverse populations. |
Updated assessment of state food safety laws for norovirus outbreak prevention in the United States
Kambhampati AK , Hoover ER , Landsman LA , Wittry BC , Brown LG , Mirza SA . J Food Prot 2025 100501 ![]() Foodborne norovirus outbreaks are often associated with food contamination during preparation by an ill employee. The US Food and Drug Administration's Food Code outlines food safety provisions to prevent illness transmission in food establishments. An updated full version of the Food Code is released every four years; adoption of specific provisions is at the discretion of state governments. Food safety laws of the 50 states and District of Columbia (51 jurisdictions) were assessed for adoption as of March 2020, of four norovirus-related provisions included in the 2017 Food Code: 1) prohibition of barehand contact with ready-to-eat (RTE) food, 2) exclusion of food employees with vomiting or diarrhea, 3) person in charge being a certified food protection manager (CFPM), and 4) written response plan for vomiting or diarrheal events. We compared the frequency of adoption of the 2017 Food Code provisions to a previous assessment of adoption of these provisions in the 2013 Food Code. Prohibition of barehand contact with RTE food was adopted by 45 jurisdictions (88%), an increase from 39 jurisdictions (76%) in the previous analysis. Forty jurisdictions (78%) required exclusion of food employees with vomiting or diarrhea for ≥24 hours after symptom cessation, an increase from 30 jurisdictions (59%). Provisions requiring the person in charge to be a CFPM and written response plan for contamination events were new to the 2017 Food Code; 5 jurisdictions (10%) required the person in charge to be a CFPM and 9 (18%) required a written response plan. Adoption of provisions prohibiting barehand contact with RTE food and requiring exclusion of ill food employees increased. Newer provisions, requiring a person in charge as a CFPM and a written contamination response plan, were not as widely adopted. Increased adoption of Food Code provisions and improved compliance may decrease norovirus transmission in food establishments. |
Changes in hand hygiene knowledge, attitudes, and practices among primary school students: Insights from a promotion program in Guatemala
Pieters MM , Fahsen N , Craig C , McDavid K , Ishida K , Hug C , Vega Ocasio D , Cordón-Rosales C , Lozier MJ . Int J Environ Res Public Health 2025 22 (3) ![]() School-aged children are vulnerable to infectious diseases due to their developing immune systems and frequent social interactions. The COVID-19 pandemic underscored the importance of non-pharmaceutical interventions, like hand hygiene (HH). This study evaluated the changes achieved through a school-based intervention to Guatemalan primary school students’ HH knowledge, attitudes, and self-reported practices while collecting teacher feedback to inform future efforts. The intervention included handwashing festivals, environmental nudges, and the regular delivery of soap and alcohol-based hand rub (ABHR). Knowledge, attitudes, and practices (KAP) surveys were conducted pre- and post-intervention with 109 and 144 students, respectively. Six teachers participated in interviews to provide perspectives. Significant improvements were observed in students’ knowledge of HH’s role in preventing disease (pre: 84.4%; post: 96.5; p < 0.01) and recognition of critical moments (pre: 84.4%; post: 92.4%; p < 0.05). Self-reported practices also improved, with more students reporting washing their hands for 20 s or more (pre: 68.8%; post: 79.9%; p < 0.05). Fewer students reported liking ABHR after the intervention (pre: 89%; post: 78.5%; p < 0.05). Teachers reported increased HH practices and provided feedback to enhance interventions. These findings highlight the effectiveness of school-based interventions and emphasize the importance of addressing knowledge gaps and incorporating teacher insights for sustained public health benefits. © 2025 by the authors. |
National trends in per-capita medical expenditures among U.S. adults with diabetes, 2000-2022
Tang S , Wang Y , Zhou X , Zhang P . Diabetes Res Clin Pract 2025 112154 ![]() AIMS: To examine the national trend in per-capita medical expenditures among U.S. adults with diabetes from 2000 to 2022. METHODS: We analyzed data from the Medical Expenditure Panel Survey in U.S. adults aged ≥18 years with self-reported diabetes. We calculated the expenditure in total and by component, including outpatient services, inpatient services, emergency room (ER) visits, prescription drugs, and other medical services. We used joinpoint regression to identify changes in trends. RESULTS: Estimated total per-capita expenditure increased 66 %, from $9,700 (95 % CI $8,736-$10,663) in 2000 to $16,067 (95 % CI $15,049-$17,086) in 2022. Specifically, spending on prescription drugs, outpatient, ER, and other medical services increased by 144 %, 96 %, 122 %, and 135 %, respectively, while inpatient spending decreased by 28 %. Two significant upward trend periods (2000-2004 and 2011-2018) were identified for total expenditure. Spending trends by component varied, with an accelerated increase in prescription drug spending after 2012; by 2022, prescription drugs accounted for the largest share (39 %) of total expenditures. CONCLUSIONS: The economic burden of diabetes on the national health care system has been increasing, with spending changes varying by medical service category. Interventions to prevent diabetes and its complications may help mitigate this growing economic burden. |
Spending on glucagon-like peptide-1 receptor agonists among US adults
Tsipas S , Khan T , Loustalot F , Myftari K , Wozniak G . JAMA Netw Open 2025 8 (4) e252964 ![]() This economic evaluation estimates annual total US spending on glucagon-like peptide-1 receptor agonists from 2018 to 2023. | eng |
Outpatient visits and antibiotic use due to higher valency pneumococcal vaccine serotypes
King LM , Andrejko KL , Kabbani S , Tartof SY , Hicks LA , Cohen AL , Kobayashi M , Lewnard JA . J Infect Dis 2024 230 (4) 821-831 ![]() BACKGROUND: In 2022-2023, 15- and 20-valent pneumococcal conjugate vaccines (PCV15/PCV20) were recommended for infants. We aimed to estimate the incidence of outpatient visits and antibiotic prescriptions in US children (≤17 years) from 2016-2019 for acute otitis media, pneumonia, and sinusitis associated with PCV15- and PCV20-additional (non-PCV13) serotypes to quantify PCV15/20 potential impacts. METHODS: We estimated the incidence of PCV15/20-additional serotype-attributable visits and antibiotic prescriptions as the product of all-cause incidence rates, derived from national health care surveys and MarketScan databases, and PCV15/20-additional serotype-attributable fractions. We estimated serotype-specific attributable fractions using modified vaccine-probe approaches incorporating incidence changes post-PCV13 and ratios of PCV13 versus PCV15/20 serotype frequencies, estimated through meta-analyses. RESULTS: Per 1000 children annually, PCV15-additional serotypes accounted for an estimated 2.7 (95% confidence interval, 1.8-3.9) visits and 2.4 (95% CI, 1.6-3.4) antibiotic prescriptions. PCV20-additional serotypes resulted in 15.0 (95% CI, 11.2-20.4) visits and 13.2 (95% CI, 9.9-18.0) antibiotic prescriptions annually per 1000 children. PCV15/20-additional serotypes account for 0.4% (95% CI, 0.2%-0.6%) and 2.1% (95% CI, 1.5%-3.0%) of pediatric outpatient antibiotic use. CONCLUSIONS: Compared with PCV15-additional serotypes, PCV20-additional serotypes account for > 5 times the burden of visits and antibiotic prescriptions. Higher-valency PCVs, especially PCV20, may contribute to preventing pediatric pneumococcal respiratory infections and antibiotic use. |
Vaccine effectiveness against anal HPV among men who have sex with men aged 18-45 years attending sexual health clinics in three United States cities, 2018-2023
DeSisto CL , Winer RL , Querec TD , Dada D , Pathela P , Asbel L , Lin J , Tang J , Iqbal A , Meites E , Unger ER , Markowitz LE . J Infect Dis 2025 231 (3) 751-761 ![]() BACKGROUND: We assessed human papillomavirus (HPV) vaccine effectiveness (VE) against anal HPV among men who have sex with men (MSM) in 2018-2023. METHODS: Residual anal specimens from MSM without HIV aged 18-45 years were tested for HPV. We calculated adjusted prevalence ratios (aPR) and 95% confidence intervals (CI) for associations between vaccination (≥1 dose) and quadrivalent vaccine (4vHPV)-type prevalence adjusting for city, race/ethnicity, and nonvaccine-type HPV prevalence, stratified by age group (18-26, 27-45 years). VE was calculated as (1 - aPR) × 100. RESULTS: Among 2802 persons aged 18-26, 4vHPV-type prevalence was lower in those vaccinated at age <18 (aPR = 0.13; 95% CI, .08-.22; VE = 87%) and those vaccinated ≥2 years before specimen collection (aPR = 0.52; 95% CI, .42-.64; VE = 48%) compared with unvaccinated persons. Among 3548 persons aged 27-45, 4vHPV-type prevalence was lower in those vaccinated at ages 18-26 (aPR = 0.68; 95% CI, .57-.82; VE = 32%) and those vaccinated ≥2 years before specimen collection (aPR = 0.66; 95% CI, .57-.77; VE = 33%) compared with unvaccinated persons. While we observed no VE in persons vaccinated at age >26 overall, 4vHPV-type prevalence was lower in the subgroup vaccinated ≥2 years before specimen collection (aPR = 0.71; 95% CI, .56-.89; VE = 29%). CONCLUSIONS: We found high VE against anal 4vHPV-type prevalence among MSM aged 18-26 who were vaccinated at age <18. Lower VE was observed among MSM aged 27-45 who were vaccinated at age 18-26 or ≥2 years before specimen collection. While ideally vaccination should be given at younger ages, vaccination can prevent some future infections in this population. |
Annual estimation of seasonal influenza burden in 6 South American countries: A retrospective analysis of SARInet surveillance data to inform policies
Descalzo MA , de Paula Júnior FJ , Vergara Mallegas N , Penayo E , Voto C , Goñi N , Bruno A , Ferreira da Almeida WA , Ikeda do Carmo GM , Olivares Barraza MF , Fasce R , Pacheco J , Vázquez C , Von Horoch M , Battaglia S , Giovacchini C , Baumeister E , Santoro A , Buyayisqui MP , Alegretti M , Escobar Naranjo MP , Jara JH , Nogareda F , Rodríguez Á , Alvis-Zakzuk NJ , Iuliano AD , Azziz-Baumgartner E , Tempia S , Leite JA , Rondy M , Couto P . J Infect Dis 2025 231 S123-s132 ![]() ![]() ![]() BACKGROUND: We estimate annual viral influenza-associated mild-to-moderate illness, hospitalizations, and deaths in 6 South American countries (Argentina, Brazil, Chile, Ecuador, Paraguay, and Uruguay) during the 2015-2019 influenza seasons as a first step in evaluating the full value of influenza vaccination in the subregion. METHODS: We applied a multiplier method using monthly hospital discharge and vital statistics death records, influenza surveillance data, and population projections to estimate mild-to-moderate influenza-associated illness, hospitalizations, and deaths. We estimated the uncertainty bounds based on the 2.5th and 97.5th percentiles of the Monte Carlo simulated distributions for the number of cases and obtained the ranges from the minimum value of the 2.5th and the maximum value of the 97.5th percentile. RESULTS: In selected countries with a total population of 307 million people, the yearly influenza-associated burden of disease ranged between 51 and 78 million mild-to-moderate influenza illnesses, between 323 379 and 490 049 hospitalizations, and between 22 662 and 46 971 deaths during the 2015-2019 influenza seasons. CONCLUSIONS: Each year, influenza is associated with millions of illnesses, hundreds of thousands of hospitalizations, and tens of thousands of deaths in 6 South American countries, affecting a significant portion of the population. Such findings can be used to estimate the number of illnesses averted through vaccination programs and the cost-benefit of influenza vaccines. |
Three-dose immunogenicity of the type 2 novel oral poliovirus vaccine in a campaign setting in Tajikistan: a follow-up study
Mirzoev A , Macklin G , Sifontes G , Mainou BA , Sadykova U , Huseynov S , Ruziev M , Saidzoda F , Bobokhonova M , Lopez Cavestany R , Mach O . Lancet Glob Health 2025 13 (4) e618-e619 ![]() |
Post-introduction evaluation (PIE) of the seasonal influenza vaccination program in Kyrgyzstan in 2023
Otorbaeva D , Akmatova R , Cooley KM , Iwamoto C , Jacques-Carroll LA , Jones CE , Matanock AM , Shen AK , Tupps C . Vaccine 2025 55 127052 ![]() Vaccination is an effective preventive strategy against influenza. Kyrgyzstan introduced a comprehensive influenza vaccination program in 2013 and has collaborated with the Task Force for Global Health since 2017 to expand vaccination coverage. In 2023, an influenza vaccine post-introduction evaluation was conducted to identify strengths and weaknesses in the influenza vaccination program and to identify measures for improvement. Site visits were conducted across six regions of the country and interviews were conducted with national, regional and district staff, health facility staff, and individuals from priority populations for influenza vaccination using standardized questionnaires. Two major challenges identified in this evaluation were the inadequate supply of influenza vaccine to cover the priority groups and the low acceptance and uptake of influenza vaccine among pregnant people. These findings are important as they can inform targeted strategies and policy updates to increase influenza vaccine implementation and uptake in Kyrgyzstan. |
Patient- and community-level characteristics associated with respiratory syncytial virus vaccination
Surie D , Yuengling KA , Safdar B , Ginde AA , Peltan ID , Brown SM , Gaglani M , Ghamande S , Gottlieb RL , Columbus C , Mohr NM , Gibbs KW , Hager DN , O'Rourke M , Gong MN , Mohamed A , Johnson NJ , Steingrub JS , Khan A , Duggal A , Wilson JG , Qadir N , Chang SY , Mallow C , Busse LW , Felzer J , Kwon JH , Exline MC , Vaughn IA , Ramesh M , Lauring AS , Martin ET , Mosier JM , Harris ES , Baughman A , Swan SA , Johnson CA , Blair PW , Lewis NM , Ellington S , Rutkowski RE , Zhu Y , Self WH , Dawood FS . JAMA Netw Open 2025 8 (4) e252841 ![]() IMPORTANCE: In 2023, the first respiratory syncytial virus (RSV) vaccines were recommended for US adults 60 years or older, but few data are available about which patients were most likely to receive vaccine to inform future RSV vaccine outreach efforts. OBJECTIVE: To assess patient- and community-level characteristics associated with RSV vaccine receipt and patient knowledge and attitudes related to RSV disease and RSV vaccines. DESIGN, SETTING, AND PARTICIPANTS: During the first season of RSV vaccine use from October 1, 2023, to April 30, 2024, adults 60 years or older hospitalized with RSV-negative acute respiratory illness were enrolled in this cross-sectional study from 26 hospitals in 20 US states. Sociodemographic and clinical data were abstracted from health records, and structured interviews were conducted for knowledge and attitudes about RSV disease and RSV vaccines. EXPOSURES: Age, sex, race and ethnicity, pulmonary disease, immunocompromised status, long-term care facility residence, medical insurance, social vulnerability index (SVI), and educational level. MAIN OUTCOMES AND MEASURES: The exposures were identified a priori as possible factors associated with RSV vaccine receipt and were entered into a modified Poisson regression model accounting for state clustering, to assess for association with RSV vaccine receipt. Knowledge and attitudes were summarized with frequencies and proportions. RESULTS: Among 6746 hospitalized adults 60 years or older, median age was 73 (IQR, 66-80) years and 3451 (51.2%) were female. Among the 6599 patients with self-reported race and ethnicity, 699 (10.6%) were Hispanic, 1288 (19.5%) were non-Hispanic Black, 4299 (65.1%) were non-Hispanic White, and 313 (4.7%) were other race or ethnicity. There were 700 RSV-vaccinated (10.4%) and 6046 unvaccinated (89.6%) adults. Among 3219 unvaccinated adults who responded to RSV knowledge questions, 1519 (47.2%) had not heard of RSV or were unsure; 2525 of 3218 (78.5%) were unsure if they were eligible for RSV vaccine or thought they were not. In adjusted analyses, characteristics associated with RSV vaccination were being 75 years or older (adjusted risk ratio [ARR], 1.23; 95% CI, 1.10-1.38, P < .001), being male (ARR, 1.15; 95% CI, 1.01-1.30; P = .04), and having pulmonary disease (ARR, 1.39; 95% CI, 1.16-1.67; P < .001), immunocompromised status (ARR, 1.30; 95% CI, 1.14-1.48; P < .001), low (ARR, 1.47; 95% CI, 1.18-1.83, P < .001) or moderate (ARR, 1.47; 95% CI, 1.21-1.79; P < .001) SVI, and educational level consisting of 4 or more years of college (ARR, 2.91; 95% CI, 2.14-3.96; P < .001), at least some college or technical training (ARR, 1.85; 95% CI, 1.35-2.53; P < .001), or grade 12 education or General Educational Development (ARR, 1.44; 95% CI, 1.03-2.00; P = .03). RSV vaccination was less likely among residents of long-term care facilities, patients with Medicaid coverage, and uninsured patients. CONCLUSIONS AND RELEVANCE: In this cross-sectional study of hospitalized adults, knowledge of RSV disease and RSV vaccine eligibility was low. Older adults and those with certain medical conditions were more likely to have received vaccine, suggesting appropriate prioritization, but sociodemographic differences in vaccine uptake occurred. |
Completeness of data on race and ethnicity and timeliness of electronic case reports for COVID-19 at 4 health care organizations in Florida, December 2020
Conn LA , MacDonald G , Campbell B , Eisenstein L , Culpepper A , Fawaz S , Warren VR , Prahlow B , Sheppard M , Carey K , Sunnassee E , Yusuf H , Ritchey MD . Public Health Rep 2025 333549241308414 ![]() OBJECTIVES: Electronic case reporting (eCR), a cornerstone of the Centers for Disease Control and Prevention's (CDC's) Data Modernization Initiative, automates bidirectional information sharing between electronic health records and public health agencies for reportable conditions. eCR grew rapidly in response to the COVID-19 pandemic. CDC and the Florida Department of Health (FDOH) collaborated to compare the completeness and timeliness of eCR with that of traditional reporting methods for COVID-19-related patient encounters at 4 health care organizations in Florida in December 2020. METHODS: Electronic initial case reports (eICRs) were matched to corresponding (ie, for same patient encounter) electronic laboratory reports (ELRs) or manually transmitted documents. We extracted and compared selected data from each report type across matched reports for completeness and timeliness. RESULTS: Most (>98%) eICRs provided earlier notification of COVID-19 to the local public health department than corresponding ELRs or manually transmitted documents. Additionally, eICRs provided more data on race and ethnicity (>90%) than ELRs (71%) or manually transmitted documents (<5%). CONCLUSIONS: Advancing implementation of eCR nationwide may provide more complete and timely case data than ELR or manually transmitted documents to guide public health action. |
Systematic review of infodemiology studies using artificial intelligence: social media posts on HIV pre-exposure prophylaxis
Kamitani E , DeLuca JB , Mizuno Y . Aids 2025 ![]() ![]() OBJECTIVES: To explore how artificial intelligence (AI) can enhance infodemiology, which distributes and scans information in the electronic medium, to process social media posts for HIV pre-exposure prophylaxis (PrEP). DESIGN: Systematic Review. METHODS: We searched in the U.S. Centers for Disease Control and Prevention's Prevention Research Synthesis database through June 2024 (PROSPERO: CRD42023458870). We included infodemiology studies published in English and reported using AI to process social media posts on PrEP. Two reviewers independently screened citations, extracted data, and conducted a risk of bias assessment using the Joanna Briggs Institute Critical Appraisal Checklist for Prevalence Studies. Findings are narratively summarized. RESULTS: Of the 135 citations screened, eight infodemiology studies were identified, analyzing over 58.9 million posts. Infodemiology studies found the PrEP topics commonly discussed in communities (e.g., barriers of uptake), rumors that may raise public health concerns (e.g., PrEP is a prevention method against COVID-19 infection), geographic locations where concerns regarding risk of acquiring HIV were raised (e.g., most HIV-related posts were from the 10 states with the highest numbers of new HIV diagnoses), and predicted HIV trends (e.g., HIV-related tweets were negatively correlated with the county-level HIV incidence rate in the following year). CONCLUSIONS: Despite the limitations of this review including a small number of studies reviewed, our review suggests social media posts may provide information on real-time PrEP-related concerns, and AI can accelerate and enhance the processing of mass data to identify the information that communities need and the areas/locations that may need HIV prevention intervention. |
Pediatric traumatic brain injury and social determinants of health
Chan V , Wirianto CS , Balogh R , Haarbauer-Krupa J , Escobar MD . JAMA Pediatr 2025 ![]() This cohort study examines incident and subsequent health care visits associated with traumatic brain injury and stratified by social determinants of health. | eng |
Comparison of question wording for self-reported traumatic brain injuries among adults: findings from the 2023 SummerStyles survey
Waltzman D , Kuku R , Peterson A , Breiding M , Daugherty J . Inj Prev 2025 ![]() BACKGROUND: Surveillance of traumatic brain injury (TBI) in the USA has historically relied on healthcare administrative datasets, but these methods likely undercount the true burden of TBI. Self-report measures may help obtain more comprehensive estimates. A fundamental question is whether TBI prevalence estimated through self-report varies by whether and how TBI signs and symptoms are ascertained in the survey question(s). METHODS: Self-report data were collected from 4303 adults in the summer wave of Porter Novelli's 2023 ConsumerStyles survey. Respondents were randomised to receive a question about their 12-month experience of head injury and a grouped list of TBI signs/symptoms or a question about their 12-month experience of head injury and an option to select individual TBI signs and symptoms that resulted from the head injury. All respondents who indicated they experienced a head injury received a set of follow-up questions. RESULTS: A significantly higher percentage of people who received the 'individual signs/symptoms' question self-reported a TBI (8.3%) than those who received the 'grouped signs/symptoms' question (4.3%) χ(2)=19.6, p<0.0001. Among TBI cases identified, there were no statistical differences between question type in relation to whether the respondent reported being evaluated for or diagnosed with a TBI, nor any demographic differences. CONCLUSIONS: These results demonstrate that how TBI is ascertained in a survey can meaningfully impact reporting of TBI prevalence and provides evidence that question wording and structure affect estimates on national surveys. |
Evaluation of a rapid lateral flow assay for the detection of taeniosis and cysticercosis at district hospital level in Tanzania: A prospective multicentre diagnostic accuracy study
Van Damme I , Trevisan C , Kabululu M , Stelzle D , Makasi CE , Schmidt-Urbaneja V , Mwape KE , Mubanga C , Zulu G , Møller KS , Jansen F , Reynders D , Noh J , Handali S , Bottieau E , Winkler AS , Dorny P , Magnussen P , Gabriël S , Ngowi B . PLoS Negl Trop Dis 2025 19 (3) e0012310 ![]() The TS POC test, Taenia solium point-of-care test, is a two-strip lateral flow assay using the recombinant antigen rES33 on the TS POC T test strip, and rT24H on the TS POC CC test strip, to detect antibodies against T. solium taeniosis and cysticercosis, respectively. The objective of this study was to assess the diagnostic performance of the TS POC test for the detection of T. solium taeniosis and cysticercosis in individuals attending district hospitals in Tanzania. In this prospective two-phase diagnostic accuracy study, we recruited participants aged 10 and above, excluding pregnant women and those with acute severe illness. Participants were consecutively recruited in three cohorts according to their signs/symptoms: compatible with neurocysticercosis (cohort 1), intestinal worm infections (cohort 2), and other signs/symptoms (cohort 3). Lacking a gold standard test for both infections, diagnostic accuracy was evaluated using results of two coprological and two serological tests for taeniosis, and three serological tests for cysticercosis, in a Bayesian Latent Class Model approach. The TS POC test was conducted on 601 participants in cohort 1, 1661 participants in cohort 2, and 662 participants in cohort 3. Most individuals tested negative on both TS POC test strips, with proportions of 83% (n = 496), 97% (n = 1613) and 97% (n = 641) in cohorts 1, 2 and 3, respectively. Complete case data were available for 120, 114, and 53 participants for taeniosis, and 126, 122, and 55 participants for cysticercosis. Sensitivity values for the TS POC T test strip were 50.2% [95% credible interval 4.9 - 96.4], 40.8% [2.2 - 95.2], and 40.4% [2.3 - 95.0], while specificity values were 98.6% [97.1 - 99.6], 99.3% [98.7 - 99.7] and 99.4% [98.5 - 99.9], respectively. For the TS POC CC test strip, the sensitivity was 77.5% [37.8 - 99.2], 24.9% [95% CI 6.4 - 52.7] and 44.2% [6.6 - 91.5], and the specificity 92.3% [86.5 - 98.8], 99.1% [97.8 - 100], and 98.1% [96.1 - 99.7] across the respective cohorts. Although the TS POC test has a low sensitivity, it demonstrates a high specificity, which may have clinical utility to guide treatment and diagnostic decisions, or in epidemiological studies. An important strength of this study lies in its assessment of the TS POC test under real-world conditions, revealing divergent estimates across distinct cohorts. The study underscores the suboptimal performance of existing tests under field conditions, emphasizing the need to enhance and validate these tests for better performance in practical real-world settings. Registration number: PACTR201712002788898. |
Pediatric vital signs: An initiative to protect the health of every child and improve the future
Kaminski JW , Houry D . Pediatrics 2025 155 ![]() |
Perceived feasibility of a multicomponent prenatal intervention on childhood vaccinations: Findings from a national cross-sectional survey of prenatal care providers, April-June 2022
Vasudevan L , Porter RM , Stinnett SS , Hart L , Turner EL , Zullig LL , Vogt TM , Swamy GK , Walter EB , Bednarczyk RA , Orenstein WA , Gray B . Int J Gynaecol Obstet 2025 ![]() ![]() BACKGROUND: There are inadequate proactive interventions that take advantage of medical contacts during pregnancy to build confidence in vaccines recommended for children after birth. In addition, prenatal providers' perceptions on implementing such proactive childhood vaccination-focused interventions are not well understood. METHODS: A multicomponent prenatal intervention on childhood vaccines was designed for expectant parents to include a prenatal provider recommendation encouraging age-appropriate vaccines for children after birth, an educational website on vaccine recommendations and resources, and a phone consultation with a vaccine navigator during pregnancy. Members of national prenatal provider organizations in the USA were recruited from April to June 2022 for an online cross-sectional survey to assess their demographic and practice characteristics, perceived role as vaccine advocates, training needs, perceived intervention feasibility, and perceived implementation factors. RESULTS: After data validation, 495 of 1677 responses were included for analysis. Providers expressed agreement (65.1%) with the importance of discussing vaccinations with others, but fewer (46.7%) agreed that they changed people's views on vaccination. Over half of providers agreed or completely agreed that the proposed intervention was feasible, as measured through the four-item Feasibility of Intervention Measure (% agreement range reported across items for educational website: 71.4%-75.2%; provider recommendation: 54.0%-59.7%; and vaccine navigator: 53.9%-56.7%). Availability of adequate staff resources (48.0%), time constraints (47.8%), and adequate training on childhood vaccines (45.4%) were the top three perceived implementation challenges. Perceived facilitators included availability of patient education resources on childhood vaccines (57.7%). CONCLUSION: The proposed intervention to build confidence in childhood vaccines was perceived by providers to be feasible in prenatal settings. Supportive strategies that reduce time and staff burden and increase provider competency to discuss childhood vaccines will be necessary to overcome perceived implementation challenges. Intervention feasibility and implementation factors should be reassessed upon actual implementation of the intervention. |
Distributed acoustic sensing (DAS) for longwall coal mines
Chambers D , Ankamah A , Tourei A , Martin ER , Dean T , Shragge J , Hole JA , Czarny R , Goldswain G , du Toit J , Boltz MS , McGuiness J . Int J Rock Mech Min Sci 2025 189 ![]() Seismic monitoring of underground longwall mines can provide valuable information for managing coal burst risks and understanding the ground response to extraction. However, the underground longwall mine environment poses major challenges for traditional in-mine microseismic sensors including the restricted use of electronics due to potentially explosive atmospheres, the need to frequently and quickly relocate sensors as rapid mining progresses, and source parameter errors associated with complex time-dependent velocity structure. Distributed acoustic sensing (DAS), a technology that uses rapid laser pulses to measure strain along fiber-optic cables, shows potential to alleviate these shortcomings and improve seismic monitoring in coal mines when used in conjunction with traditional monitoring systems. Moreover, because DAS can acquire measurements that are not possible to record with traditional seismic sensors, it also enables entirely new monitoring approaches. This work demonstrates several DAS deployment strategies such as deploying fiber on the mine floor, in boreholes drilled from the surface and from mine level, on the longwall mining equipment, and wrapped around secondary support cans. Although there are several data processing and deployment improvements needed before DAS-based monitoring can become routine in underground longwall mines, the findings presented here can aid decision makers in assessing the potential of DAS to meet their needs and help guide future deployment designs. © 2025 |
Computer vision and tactile glove: A multimodal model in lifting task risk assessment
Chen H , Liu P , Zhou G , Lu ML , Yu D . Appl Ergon 2025 127 104513 ![]() ![]() Work-related injuries from overexertion, particularly lifting, are a major concern in occupational safety. Traditional assessment tools, such as the Revised NIOSH Lifting Equation (RNLE), require significant training and practice for deployment. This study presents an approach that integrates tactile gloves with computer vision (CV) to enhance the assessment of lifting-related injury risks, addressing the limitations of existing single-modality methods. Thirty-one participants performed 2747 lifting tasks across three lifting risk categories (LI < 1, 1 ≤ LI ≤ 2, LI > 2). Features including hand pressure measured by tactile gloves during each lift and 3D body poses estimated using CV algorithms from video recordings were combined and used to develop prediction models. The Convolutional Neural Network (CNN) model achieved an overall accuracy of 89 % in predicting the three lifting risk categories. The results highlight the potential for a real-time, non-intrusive risk assessment tool to assist ergonomic practitioners in mitigating musculoskeletal injury risks in workplace environments. |
Exposure to ethylene oxide and relative rates of female breast cancer mortality: 62 years of follow-up in a large US occupational cohort
Kelly-Reif K , Bertke SJ , Stayner L , Steenland K . Environ Health Perspect 2025 ![]() BACKGROUND: Ethylene oxide (EtO) is a recognized carcinogen of concern in occupational and environmental settings, but evidence of cancer risks in humans remains limited. Since new EtO emission standards and mitigation measures have been proposed, further investigation of EtO cancer risks is needed to inform quantitative risk assessment. OBJECTIVE: Our objective was to estimate the association between cumulative EtO exposure and risk of death from breast cancer. METHODS: We had data on 7,549 women from the largest cohort of EtO-exposed workers who were employed for at least 1 year at one of 13 US facilities, with mortality follow-up from January 1, 1960, to December 31, 2021. We estimated relative rates (RR) of the association between cumulative EtO exposure [parts per million days (ppm-days)] and breast cancer mortality using Cox proportional hazard models, using a matched risk-set sampling design with attained-age as the underlying time scale. We further examined a subcohort of women who participated in interviews which contained information about breast cancer risk factors. RESULTS: Cumulative exposure to EtO was associated with elevated RRs of breast cancer mortality (181 deaths). In a log-log model with a 20-year lag fit, workers who accrued 3,650 ppm-days of exposure (equivalent to 10 years exposed at a rate of 1 ppm) had over three times the rate of breast cancer death compared to unexposed workers (RR at 3,650 ppm-days = 3.15; 95%CI: 1.78, 5.60). This RR remained elevated for the subset of the cohort with interview data after matching on potential confounders (RR at 3,650 ppm-days = 3.22; 95%CI: 1.52, 7.13). We observed evidence of variation in RRs by time since exposure and exposure rate. DISCUSSION: This updated analysis of an EtO exposed worker cohort builds upon evidence that EtO is a human breast carcinogen and supports recent exposure reduction proposals. Given the high prevalence of breast cancer, the large number of workers exposed to EtO, and the potential for widespread environmental exposure, increased risks observed even in the low exposure range are of serious public health importance. https://doi.org/10.1289/EHP15566. |
Development of an early-stage thermal runaway detection model for lithium-ion batteries
Tam WC , Chen J , Fang H , Tang W , Deng J , Putorti A . J Power Sources 2025 641 ![]() This paper presents the development of a fast-responding and accurate detection model for early-stage thermal runaway of a lithium-ion battery utilizing acoustics and deep learning paradigms. A series of single-cell battery tests with different state-of-charge and battery orientations is conducted to collect acoustic data. Using data augmentation, 1330 acoustic samples of early-stage thermal runaway are obtained. To facilitate the development of a detection model that can be used in real-life settings, 1128 acoustic samples, including various human activities, are also used. Utilizing 10-s acoustic data as the input and a convolutional neural network model structure as the backbone, excellent model performance is achieved. The overall accuracy is about 93 % with a precision and recall score of about 92 % and 97 %, respectively. Parametric studies are also carried out to evaluate the robustness of the proposed model structure and the effectiveness of the data augmentation methods. In addition, the model performance against two entire tests is assessed using leave-one test-out cross-validation. It is hoped that the proposed work can help to develop a robust detection device that can provide early warning of thermal runaways and allow users to have extra time to mitigate the potential extreme fire hazards and/or to safely evacuate. © 2025 |
False alarm on a malaria "outbreak" linked to inconsistencies in malaria diagnostic supply: a call to strengthen supply chain management: Sierra Leone, May-July 2023
DeVita TN , Kabia AB , Khobi JAM , Malimbo M , Kamara S , Magoba B , Gebru GN , Jammeh AH , Painter JA , Ansumana TK , Sillah-Kanu M , Schnabel DC . Malar J 2025 24 (1) 100 ![]() BACKGROUND: Malaria transmission in Sierra Leone is intense and perennial, accounting for 40% of clinical consultations. Medical workers diagnose suspected malaria cases using rapid diagnostic tests (RDT) and microscopy, with facility-level results reported to the Health Management Information System (HMIS) as monthly aggregates. Commodity stocks are reported to the Logistics Management Information System (LMIS). Partners investigated a striking increase in confirmed malaria during May-July 2023 in Sierra Leone, peaking in June to 46% above the June 2018-2022 mean. METHODS: The team first analysed national, district, and facility HMIS/LMIS data for RDT stocks, testing rates, and confirmed cases during January 2018-October 2023. Epidemic thresholds, defined as case counts two standard deviations (σ) above the previous 5 years' monthly mean, were assessed. Then four facilities in two districts were visited to interview staff. Lastly, the team reanalysed LMIS RDT stock data for all facilities in Sierra Leone using R to categorize their stock status by month. RESULTS: National epidemic thresholds were surpassed in May (2.56σ) and June (4.81σ) 2023. Twelve of sixteen districts surpassed epidemic thresholds during May-June. Investigation revealed inconsistent RDT distribution to facilities over time. National RDT distribution spiked in May 2023, when 551,888 RDT test kits were delivered. This was substantially larger than the 2019-2022 mean for May (53,121, 1,000% increase) and all months (126,866, 435% increase). Subsequently in June 2023, 386,343 tests were performed, 36% higher than the June 2018-2022 mean (285,123). Staff at all four visited facilities reported recurrent RDT stockouts. The proportion of facilities in Sierra Leone reporting positive RDT stocks at both the start and end of the month increased from 14% in April to 74% in June. 51% of facilities began May with RDT stockout and received RDTs that month. CONCLUSIONS: The 2023 spike in confirmed malaria was likely related to increased testing following an unusually large distribution of RDTs. Fluctuations in RDT availability impede the ability to recognize true case variations. Sierra Leone and its partners can strengthen supply chain logistics and health commodity stock tracking to ensure a consistent supply of RDTs and improve interpretation of surveillance data. |
How, why, and under what circumstances can supportive supervision programs improve malaria case management? A realist program theory
Manzi F , Hamon JK , Agbodjavou MK , Hoyt J , Kuwawenaruwa A , Kionga Y , Agossou C , Kabanywanyi AM , Boyi-Hounsou C , Lusasi A , Lazaro S , Saliou R , Kpemasse A , Reaves E , Kitojo C , Hassani AS , Gnanguenon V , Dossou JP , Webster J . Health Policy Plan 2025 ![]() Supportive supervision (SS) programs aim to enhance the quality of care by strengthening the performance of health providers. Commonly part of broader quality improvement efforts, SS programs are increasingly used in low-and middle-income countries to improve malaria case management. Despite substantial investments and some positive outcomes, little is known about what drives their effectiveness. A realist evaluation was conducted in Tanzania and Benin to explain how, why, and under what circumstances SS programs can improve the facility-based management of uncomplicated malaria in children under five. A program theory was developed through a team-based analysis of empirical data collected in both countries at two time points. Data included 218 in-depth and 12 structured interviews with stakeholders, 154 audits of febrile case management decisions, and four health facility audits. Stakeholder perspectives identified three acceptability mechanisms driving SS program outcomes in the studied contexts: the affective attitude, self-efficacy, and burden of the program as perceived by key actors. The pathway through which these mechanisms were perceived to shape malaria case management (diagnosis and treatment) practices was defined by the 1) extent to which the program was integrated into the public health system; 2) frequency with which SS visits were conducted by appropriate supervisors; 3) degree to which supervisors coached, rather than policed, supervisees; and 4) level of collaboration achieved between supervisees and supervisors. The program actors' perception of the program's effectiveness was also found to be crucial to its sustainability. This study explains the dynamics driving SS program outcomes and underscores the role played by the cognitive and emotional responses of program actors. These insights are likely to be transferable to other settings with similar contexts and can help inform the design, implementation, monitoring, and evaluation of new and ongoing SS programs. |
Prevalence of subpatent Plasmodium falciparum infections in regions with varying transmission intensities and implications for malaria elimination in Mainland Tanzania
Seth MD , Popkin-Hall ZR , Madebe RA , Budodo R , Bakari C , Lyimo BM , Giesbrecht D , Moshi R , Mbwambo RB , Francis F , Pereus D , Mbata D , Challe DP , Mandai SS , Chacha GA , Kisambale AJ , Mbwambo D , Aaron S , Lusasi A , Lazaro S , Mandara CI , Bailey JA , Juliano JJ , Gutman JR , Ishengoma DS . Malar J 2025 24 (1) 101 ![]() ![]() BACKGROUND: Subpatent Plasmodium falciparum infections, defined as infections with parasite density below the detection limit of routine malaria diagnostic tests, contribute to infectious reservoirs, sustain transmission, and cause the failure of elimination strategies in target areas. This study assessed the prevalence of subpatent P. falciparum infections and associated risk factors in 14 regions of Mainland Tanzania. METHODS: The study used samples randomly selected from RDT-negative dried blood spots (DBS) (n = 2685/10,101) collected in 2021 at 100 health facilities across 10 regions of Mainland Tanzania, and four communities in four additional regions. The regions were selected from four transmission strata; high (five regions), moderate (three regions), low (three regions), and very low (three regions). DNA was extracted by Tween-Chelex method, and the Pf18S rRNA gene was amplified by quantitative polymerase chain reaction (qPCR). Logistic regression analysis was used to assess the associations between age groups, sex, fever status, and transmission strata with subpatent infection status, while linear regression analysis was used to assess the association between these factors and subpatent parasite density. RESULTS: Of the selected samples, 525/2685 (19.6%) were positive by qPCR for P. falciparum, and the positivity rates varied across different regions. Under-fives (aOR: 1.4, 95% CI 1.04-1.88; p < 0.05) from health facilities had higher odds of subpatent infections compared to other groups, while those from community surveys (aOR: 0.33, 95% CI 0.15-0.72; p = 0.005) had lower odds. Participants from very low transmission stratum had significantly lower odds of subpatent infection compared to those from high transmission stratum (aOR = 0.53, 95% CI = 0.37-0.78; p < 0.01). The log-transformed median parasite density (interquartile range) was 6.9 (5.8-8.5) parasites/µL, with significantly higher parasitaemia in the low transmission stratum compared to a very low one (11.4 vs 7.0 parasites/µL, p < 0.001). CONCLUSION: Even in very low transmission settings, the prevalence of subpatent infections was 13%, and in low transmission settings it was even higher at 29.4%, suggesting a substantial reservoir that is likely to perpetuate transmission but can be missed by routine malaria case management strategies. Thus, control and elimination programmes may benefit from adoption of more sensitive detection methods to ensure that a higher proportion of subpatent infections are detected. |
Reproductive health counseling and outcomes among women with congenital heart defects: Results from the congenital heart survey to recognize outcomes, needs, and well-being, 2016-2019
Galindo MK , Klewer SE , Downing KF , Takamatsu CL , Seckeler MD , Oster ME , Collins RT 2nd , Nembhard WN , Bolin EH , Farr SL . Womens Health Issues 2025 35 (2) 65-73 ![]() BACKGROUND: Guidelines recommend tailored reproductive health counseling for women with congenital heart defects (CHDs) beginning in adolescence, yet provider adherence to recommendations remains understudied, particularly outside specialized cardiac care settings. STUDY DESIGN: We conducted a cross-sectional cohort study among women aged 19 to 38 with CHDs, identified from active population-based birth defects registries in three states. Participants completed surveys from 2016 to 2019, including questions about contraception, pregnancy counseling, concerns, and experiences. Multivariable Poisson regression, adjusted for sociodemographic and health characteristics, assessed associations between CHD severity, counseling, and reproductive health outcomes. RESULTS: Of 765 women, those with severe CHDs, compared with non-severe, were more likely to report receiving clinician counseling about safe contraceptive methods (44.0% and 13.7%; adjusted prevalence ratio [aPR] = 3.0; 95% confidence interval [95% CI] [2.2, 4.0]), pregnancy, (63.3% and 16.5%; aPR = 3.6; 95% CI [2.7, 4.6]), and pregnancy avoidance (32.0% and 6.4%; aPR = 4.3; 95% CI [2.9, 6.6]); be concerned about ability to have children (40.9% and 31.2%; aPR = 1.4; 95% CI [1.1, 1.8]), and delay/avoid pregnancy (26.6% and 10.7%; aPR = 2.2; 95% CI [1.5, 3.2]). No disparity was found in ever being pregnant (30.0% vs. 37.2%; aPR = 1.0; 95% CI [0.7, 1.2]). One-third of the respondents with any CHD reported concerns about their ability to have children (33.6%). CONCLUSION: We found that only a minority of women with CHDs reported receiving counseling on safe contraception and pregnancy, and about a third reported concerns about their ability to have children. These findings highlight a gap between guideline recommendations and clinical practice, underscoring the need for improved reproductive health discussions for women with CHDs. |
Synthetic opioid and stimulant co-involved overdose deaths by occupation and industry - United States, 2022
Lundstrom EW , Macmadu A , Steege AL , Groenewold M . MMWR Morb Mortal Wkly Rep 2025 74 (10) 173-178 ![]() The proportion of synthetic opioid overdose deaths co-involving stimulants has increased in the United States in recent years. Although persons who use opioids have reported increasing stimulant co-use to maintain workplace productivity and alertness, occupational patterns of co-involvement in fatal overdose have not been systematically investigated. In an exploratory study, data on overdose deaths involving synthetic opioids (e.g., fentanyl) from the 2022 National Vital Statistics System were analyzed to characterize patterns of stimulant co-involvement among U.S. residents aged 15-64 years, stratified by decedents' usual occupation and industry. Of 69,893 fatal synthetic opioid overdoses, 53.6% involved stimulants. Occupation and industry groups with the highest percentages of synthetic opioid overdose deaths co-involving psychostimulants with abuse potential (psychostimulants) were typically physically demanding (e.g., construction and extraction occupations), whereas categories with highest percentages of cocaine co-involvement were generally less physically strenuous (e.g., business and financial occupations); these patterns might reflect differences in desired drug effects, cost, and geographic availability. Work-related interventions might be useful in preventing the development of substance use disorder by decreasing rates of occupational injuries and workplace stress, connecting workers with substance use disorder to treatment resources, and reducing fatal overdose through harm reduction. |
Prenatal maternal alcohol exposure during the first trimester of pregnancy in relation to early learning ability, behavioral problems, and autistic traits in preschool children with or without autism spectrum disorder
Tian LH , Barger B , Pazol K , Schieve LA , Bertrand J , DiGuiseppi C , Summers AD , Dunajcik A , England L , Crume TL , Wiggins LD . Autism Res 2025 ![]() Prenatal alcohol exposure has been linked to adverse neurodevelopmental outcomes. However, its effects on developmental outcomes in children with autism spectrum disorder (ASD) remain unclear. We examined associations between prenatal alcohol exposure during the first trimester (PAE-FT) and early learning ability, behavioral problems, and severity of autistic traits in preschool-aged children in a large multi-site case-control study, the Study to Explore Early Development. Children were classified as ASD (n = 1237) or population comparison without ASD (POP, n = 1334) after an in-person assessment covering cognitive abilities and detailed autistic traits. Mothers completed questionnaires on their child's behavior and autism-related traits, as well as their alcohol use during pregnancy. Of children in the ASD and POP groups, 18.5% and 20.2%, respectively, were exposed to PAE-FT. Exposure to 3 or more alcoholic drinks per week was associated with increased externalizing behaviors (i.e., attention deficits and aggressive behaviors) in children in both the ASD and POP groups, and with exacerbated social communication and interaction deficits in children with ASD only. First trimester exposure to 1-2 alcoholic drinks per week was associated with early learning delays for children in the ASD group, but not the POP group. As expected, our findings suggest that PAE-FT is associated with adverse behavioral development of children regardless of ASD status. However, PAE-FT may exacerbate autism-specific developmental problems and learning difficulties in children with ASD. Gathering a prenatal alcohol exposure history for children with and without ASD could contribute to a better understanding of developmental trajectories, aiding informed decisions for interventions and support. |
Sex- and age-specific lyme disease testing patterns in the United States, 2019 and 2022
Li Y , Matsushita F , Chen Z , Jones RS , Bare LA , Petersen JM , Hinckley AF . Public Health Rep 2025 333549251314419 ![]() OBJECTIVES: Serologic testing is a useful adjunct for the diagnosis of Lyme disease, a major public health problem in certain US regions. We aimed to determine whether Lyme disease serologic testing and results differed by sex and age group. METHODS: We identified 2 cohorts of individuals across all ages who underwent serologic testing for Lyme disease at a national reference laboratory in 2019 (cohort 1) and 2022 (cohort 2). If an individual had multiple tests in the same year, we included only the first test. We excluded individuals who had been tested in the previous 5 years. RESULTS: Cohorts 1 and 2 consisted of 578 052 and 550 674 people, respectively. Fewer males than females were tested in cohort 1 (42.7% vs 57.3%) and cohort 2 (42.3% vs 57.7%), although similar numbers were tested for both sexes among nonadults. More males than females had a positive test result in cohort 1 (53.9% more males) and cohort 2 (52.9% more males). The odds ratio of receiving a positive test result among males versus females was 2.09 (95% CI, 2.01-2.17) in cohort 1 and 2.12 (95% CI, 2.05-2.19) in cohort 2. Among people with positive test results, females (except children) were more likely than males to have positive immunoglobulin M and negative immunoglobulin G results, which can serve as a marker of early infection (odds ratio = 1.43 [95% CI, 1.31-1.55] in cohort 1 and 1.38 [95% CI, 1.29-1.47] in cohort 2). CONCLUSIONS: Further studies are needed to understand whether the observed differences in Lyme disease testing and positivity result from sex- and age-associated disparities in social behavior, health care seeking, clinical practice, or other factors. |
Jamestown Canyon virus seroprevalence in endemic regions and implications for diagnostic testing
Sutter RA , Calvert AE , Grimm K , Biggerstaff BJ , Thrasher E , Mossel EC , Martin SW , Lehman J , Saa P , Townsend R , Krysztof D , Brown CM , Osborne M , Hopkins B , Osborn R , Lee X , Schiffman EK , Brault AC , Basavaraju SV , Stramer SL , Staples JE , Gould CV . Clin Infect Dis 2025 ![]() BACKGROUND: Jamestown Canyon virus, a mosquito-borne virus, can cause asymptomatic infection, febrile illness, or neuroinvasive disease in humans. Previous studies have found Jamestown Canyon virus-specific antibodies in a 4-54% of people in various U.S. regions. To understand baseline seroprevalence in regions with the highest number of reported disease cases, we performed a serosurvey among blood donors. METHODS: We randomly selected blood donation specimens collected during December 2019-April 2020 from residents of counties reporting ≥2 disease cases in 2019 or one case in 2019 and ≥1 case during 2010-2018. Specimens were screened for Jamestown Canyon virus-specific neutralizing antibodies and, if positive, tested for IgM antibodies. We estimated county population seroprevalence by calibrating sample weights to population census data. RESULTS: Fourteen counties in three states, Massachusetts, Minnesota, and Wisconsin, met the inclusion criteria. Within each state, average county seroprevalence ranged from 16.8% (95% CI: 9.3%-27.0%) to 18.8% (95% CI: 14.0%-24.4%) for Jamestown Canyon virus neutralizing antibodies and from 7.6% (95% CI: 4.2%-12.5%) to 13.5% (95% CI: 9.6%-18.3%) for both neutralizing and IgM antibodies. CONCLUSIONS: Estimated Jamestown Canyon virus seroprevalence, including for IgM antibodies, is elevated in endemic areas, complicating the interpretation of serologic testing in diagnosing acute disease in symptomatic individuals. Diagnosing Jamestown Canyon virus disease requires a high degree of clinical suspicion, ruling out other possible causes of illness, and if possible, collecting acute and convalescent samples. New assays to detect acute infection could improve diagnosis and public health surveillance for Jamestown Canyon virus disease. |
Sign up Email Alert
Content Index (Current Edition)
- Antimicrobial Resistance and Antibiotic Stewardship
- Chronic Diseases and Conditions
- Communicable Diseases
- Community Health Services
- Environmental Health
- Food Safety
- Health Behavior and Risk
- Health Economics
- Immunity and Immunization
- Informatics
- Injury and Violence
- Laboratory Sciences
- Maternal and Child Health
- Occupational Safety and Health
- Parasitic Diseases
- Reproductive Health
- Substance Use and Abuse
- Zoonotic and Vectorborne Diseases
About
CDC Science Clips is an online, continuously updated, searchable database of scientific literature published by CDC authors. Each article features an Altmetric Attention Score to track social and mainstream media mentions. If you are aware of a CDC-authored publication that does not appear in this database, please let us know.
Content Statistics
Top 5 Articles with Highest Altmetric Scores:Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. van Doremalen, N., et al. N Engl J Med 2020 382 (16) 1564-1567 |
Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons. Shimabukuro, T. T., et al. N Engl J Med 2021 384 (24) 2273-2282 |
Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings - Barnstable County, Massachusetts, July 2021. Brown, C. M., et al. MMWR Morb Mortal Wkly Rep 2021 70 (31) 1059-1062 |
Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021. Oster, M. E., et al. JAMA 2022 327 (4) 331-340 |
Covid-19 - Navigating the Uncharted. Fauci, A. S., et al. N Engl J Med 2020 382 (13) 1268-1269 |
Special Topics:
Genomics and Precision Health | 6440 |
Artificial Intelligence/Machine Learning | 803 |
Advanced Molecular Detection | 1874 |
Top 5 Journals with Most Publications:
MMWR Morb Mortal Wkly Rep | 2822 |
PloS one | 1439 |
Clin Infect Dis | 1434 |
Emerg Infect Dis | 1204 |
Vaccine | 1198 |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 04, 2025
- Content source:
- Powered by CDC PHGKB Infrastructure